Lanthipeptide(s) for BH0452
BH0453
Leader:
MVNSKDLRNPEFRKAQGLQFVDEVNEKELSSLAGS
Core:
GDVHAQTTWPCATVGVSVALCPTTKCTSQC
Core with dehydrations:
GDVHAQDhbDhbWPCysADhbVGVDhaVALCysPDhbDhbKCysDhbDhaQCys
antiSMASH-DB 4.0 matches for BH0453
62.5%
NZ_NUML01000015.1:
Lanthipeptides: COD66_RS20140_lanthipeptide
1
GDVHAQTT--WPCATVGVSVALCPTTKCTSQC
30
GDV +TT P VG+SV LCPTTKCTS+C
1
GDVSPETTPATPTIVVGISVGLCPTTKCTSKC
32
60.0%
NZ_JABBGE010000004.1:
Lanthipeptides: HHL19_RS13570_lanthipeptide
7
TTWPCATVG-----VSVALCPTTKCTSQC
30
TTW CA V VS + CPTTKCTSQC
1
TTWSCAVVTAVATLVSASACPTTKCTSQC
29
60.0%
NZ_LMEI01000006.1:
Lanthipeptides: ASC82_RS30550_lanthipeptide
7
TTWPCATVG-----VSVALCPTTKCTSQC
30
TTW CA V VS + CPTTKCTSQC
1
TTWSCAIVTAVATLVSASACPTTKCTSQC
29
with 102 more sequence matches
60.0%
NZ_LT630004.1:
Lanthipeptides: BQ5796_RS18310_lanthipeptide
7
TTWPCA--TVGVSVALCPTTKCTSQC
30
TT PC TV +SV++CPTTKCTSQC
2
TTLPCVGITVTISVSMCPTTKCTSQC
27
59.4%
NZ_CP036019.1:
Lanthipeptides: EXW52_RS27205_lanthipeptide
1
GDVHAQTT--WPCATVGVSVALCPTTKCTSQC
30
GDV +TT P V +SV LCPTTKCTS+C
1
GDVSPETTPATPTIVVAISVGLCPTTKCTSKC
32
58.1%
NC_018499.1:
Lanthipeptides: BCK_RS27845_lanthipeptide
1
GDVHAQTTWPCAT-VGVSVALCPTTKCTSQC
30
GDV+ +TT T V VS+ +CPTTKCTS+C
1
GDVNPETTPATPTIVAVSLGICPTTKCTSKC
31
56.7%
NZ_CP042598.1:
Lanthipeptides: FUT28_RS13815_lanthipeptide
7
TTWPCATVG----VSVALCPTTKCTSQC
30
TTW C V S++LCPTTKCTSQC
1
TTWACVAVSTIVDASISLCPTTKCTSQC
28
56.4%
NZ_CP009288.1:
Lanthipeptides: PDUR_RS29295_lanthipeptide
1
GDVHAQTT------WPCATVGVSVA--LCPTTKCTSQC
30
GDV+ +TT W C T GV+V+ LCPTTKCTSQC
2
GDVNPETTILTTSSWTCITAGVTVSASLCPTTKCTSQC
39
56.2%
NZ_CP013862.1:
Lanthipeptides: AOX59_RS09365_lanthipeptide
1
GDVHAQTTWPCATVGVSVA--LCPTTKCTSQC
30
GDV QTT G++V+ CPTTKCTSQC
1
GDVDPQTTPSSVACGIAVSALFCPTTKCTSQC
32
54.8%
NZ_MLKL01000042.1:
Lanthipeptides: BKK45_RS27405_lanthipeptide
1
GDVHAQTTWPCAT-VGVSVALCPTTKCTSQC
30
GDV+ +TT T V VSV LCPT CT C
1
GDVNPETTPATPTIVAVSVKLCPTGVCTKSC
31
53.3%
NZ_JADPDT010000005.1:
Lanthipeptides: I4V19_RS09875_lanthipeptide
7
TTWPCATVG----VSVALCPTTKCTSQC
30
TTW C V S++LCPTTKCTS+C
1
TTWACVAVSTVVEASISLCPTTKCTSKC
28
53.1%
NZ_CP006058.1:
Lanthipeptides: BAMY6639_RS19790_lanthipeptide
1
GDVHAQTT---WPCATVGVSVALCPTTKCTSQC
30
DV TT PC V V+ A CP+TKCTS C
1
ADVTPHTTPSSLPCG-VFVTAAFCPSTKCTSSC
32
53.1%
NZ_CP036019.1:
Lanthipeptides: EXW52_RS27190_lanthipeptide
1
GDVHAQTT--WPCATVGVSVALCPTTKCTSQC
30
GDV +TT P V +SV LCPT +CTS+C
1
GDVSPETTPATPTIVVAISVGLCPTNRCTSKC
32
52.6%
NC_006322.1:
Lanthipeptides: BLI_RS20290_lanthipeptide
1
GDVHAQTT------WPCATVGVSVA--LCPTTKCTSQC
30
DV+ +TT W C T GV+V+ LCPTTKCTS+C
1
NDVNPETTPATTSSWTCITAGVTVSASLCPTTKCTSRC
38
51.4%
NZ_CM000721.1:
Lanthipeptides: BCERE0010_RS29355_lanthipeptide
1
GDVHAQTTWPC-----ATVGVSVALCPTTKCTSQC
30
GDV+ +TT AT+ V+ +LCPTTKCTS+C
1
GDVNPETTPATPTIIGATIAVTASLCPTTKCTSRC
35
51.3%
NZ_CP009280.1:
Lanthipeptides: P40081_RS37160_lanthipeptide
1
GDVHAQTT------WPC--ATVGVSVALCPTTKCTSQC
30
GDV+ +TT WPC V +S LCPTTKCTS+C
2
GDVNPETTPLTTSSWPCVIGAVDISANLCPTTKCTSKC
39
50.0%
NZ_CP011152.1:
Lanthipeptides: WR47_RS28825_lanthipeptide
1
GDVHAQTTWPCATVGVSVALCPTTKCTSQC
30
GD+ QTT + V VSV PT KC+SQC
1
GDITPQTTDALSAVIVSV--LPTLKCSSQC
28
50.0%
NZ_CP017762.1:
Lanthipeptides: BKP57_RS21840_lanthipeptide
7
TTWPCATVGVSVALCPTTKCTSQC
30
TT PCA V S+ALCPT C+S+C
2
TTVPCA-VAASIALCPTLACSSKC
24
48.6%
NZ_CP015591.1:
Lanthipeptides: A7A70_RS27550_lanthipeptide
1
GDVHAQTTWPC-----ATVGVSVALCPTTKCTSQC
30
GDV+ +TT AT+ +V++CPTTKCTS+C
1
GDVNPETTPATPTIVEATIAATVSICPTTKCTSRC
35
48.5%
NZ_QORY01000016.1:
Lanthipeptides: DT250_RS18265_lanthipeptide
1
GDVHAQTTWPCATVGV-SVALCPTTKCTSQC
30
G+V TTW CA + S A CPTT C+S+C
2
GEVTPYTTWGCAIFTIASAAQCPTTACSSKC
32
47.2%
NZ_CP034118.1:
Lanthipeptides: EG886_RS06300_lanthipeptide
1
GDVHAQTTWPCAT-----VGVSVALCPTTKCTSQC
30
G+V Q+ CA V VS+A CPTT CTS C
1
GEVRPQSGPVCAVTLAVCVPVSLAFCPTTACTSDC
35
43.8%
NC_021362.1:
Lanthipeptides: BALI_RS00915_lanthipeptide
1
GDVHAQTT---WPCATVGVSVALCPTTKCTSQC
30
DV TT PC T+ V+ CP+ CTS C
1
ADVTPHTTPSSLPCGTL-VTAVWCPSNACTSDC
32
43.5%
NZ_AKXV01000031.1:
Lanthipeptides: Y19_RS44045_lanthipeptide
1
GDVHAQTTWPCATVG-----VSVALCPTTKCTSQC
30
DV+ TTW CA V VS + CPTTKCTSQC
12
ADVYGGTTWSCAIVTAVATLVSASACPTTKCTSQC
46
43.3%
NZ_CP036019.1:
Lanthipeptides: EXW52_RS27195_lanthipeptide
1
GDVHAQTT--WPCATVGVSVALCPT
23
GDV +TT P V +SV LCPT
1
GDVSPETTPATPTIVVAISVGLCPT
25
43.3%
NZ_CP040417.1:
Lanthipeptides: FE328_RS05340_lanthipeptide
7
TTWPCATVGVSVALCPTTKCTSQC
30
T+ PC TV VS A+CPT C+++C
3
TSIPC-TVMVSAAVCPTLVCSNKC
25
43.3%
NZ_JANIOB010000033.1:
Lanthipeptides: NQ113_RS28010_lanthipeptide
1
GDVHAQTTWPCATVGVSVALCPTTKCTSQ
29
GDV+ +TT P G + LCPT CT +
1
GDVNPETT-PVINPGFTNRLCPTIPCTLR
28
43.3%
NZ_LR134483.1:
Lanthipeptides: EL241_RS13590_lanthipeptide
13
TVGVSVALCPTTKCTSQC
30
TV +S+ALCPT KCTS+C
6
TVPLSIALCPTAKCTSKC
23
42.9%
NZ_BMMP01000005.1:
Lanthipeptides: IEY56_RS09415_lanthipeptide
1
GDVHAQTTWPCATVGVS-VALCPTTKCTSQC
30
D + T W CATV ++ A+CPTTKCTSQC
12
ADAYGGTAWVCATVTLATAAICPTTKCTSQC
42
42.4%
NZ_NTSF01000026.1:
Lanthipeptides: CN325_RS21840_lanthipeptide
6
QTTWPC---ATVGVSVALCPTTKCTSQC
30
TT PC +T+ +S+A CPT+KCT +C
2
STTVPCGIGSTITISIAYCPTSKCTERC
29
41.9%
NZ_KL997439.1:
Lanthipeptides: IQ62_RS33140_lanthipeptide
1
GDVHAQTT-WPCATVG-VSVALCPTTKCTSQC
30
D H T W ATV VS CPTTKCTS C
12
ADTHGGTGPWCIATVTLVSAVACPTTKCTSSC
43
40.0%
NZ_CP040938.1:
Lanthipeptides: B5772_RS02455_lanthipeptide
7
TTWPCATVGVSVALCPTTKCTSQC
30
T+ PCA V S A+CPT C+++C
3
TSIPCA-VMASTAICPTLVCSNKC
25
40.0%
NZ_JFCR01000001.1:
Lanthipeptides: JQ44_RS10210_lanthipeptide
17
SVALCPTTKCTSQC
30
SVALCPTTKC+S C
13
SVALCPTTKCSSAC
26
39.5%
NZ_GG657757.1:
Lanthipeptides: SSQG_RS41860_lanthipeptide
1
GDVHAQTT-WPCATVG-VSVALCPTTKCTSQC
30
D H T W ATV V+ +CPTTKCTS+C
12
ADNHGGTGPWCIATVTLVTATVCPTTKCTSKC
43
39.4%
NZ_JACSJU010000005.1:
Lanthipeptides: KNO78_RS14610_lanthipeptide
1
GDVHAQTTWPCATVG---VSVALCPTTKC
26
GDV +TT CA G SVA+ KC
1
GDVQPETTTLCAFTGGITFSVAMSKLFKC
29
38.6%
NZ_BNCA01000011.1:
Lanthipeptides: IE314_RS15870_lanthipeptide
4
HAQTTWP---CATVGVSVALCPTTKCTSQC
30
H TT P +V VS A CPTTKCTS+C
15
HGGTTSPVCIATSVAVSTAFCPTTKCTSKC
44
38.2%
NZ_CP036019.1:
Lanthipeptides: EXW52_RS27165_lanthipeptide
1
GDVHAQTTWPCAT---VGVSVALCPTTKCTSQC
30
GDV+ +T AT ++ LCP+ CTS+C
1
GDVNPETIPATATPILANLTKELCPSIPCTSRC
33
38.2%
NZ_JACSPO010000013.1:
Lanthipeptides: H9624_RS14885_lanthipeptide
7
TTWPCATVGVSVAL-------CPTTKCTSQC
30
TT PCA G +A+ CPT CT++C
4
TTVPCAIGGGVIAISAALPDFCPTGACTTRC
34
37.5%
NZ_CP011152.1:
Lanthipeptides: WR47_RS28835_lanthipeptide
1
GDVHAQTTWPCATV-------GVSVALCPTTKCTSQC
30
GDV Q T P T+ V A+ PT KC+S+C
1
GDVTPQAT-PTVTILATAAGGAVISAVLPTLKCSSKC
36
37.2%
NZ_CP107567.1:
Lanthipeptides: OGH68_RS19755_lanthipeptide
9
WPCATVG-VSVALCPTTKCTSQC
30
W ATV VS A+CPTTKCTS C
21
WCIATVTLVSAAMCPTTKCTSAC
43
37.1%
NZ_JALGRP010000007.1:
Lanthipeptides: MT347_RS12965_lanthipeptide
7
TTWPCATVGVSVA-------LCPTTKCTSQC
30
TT PCA G+++A CPT CT++C
2
TTAPCAVAGLTIAATAALPGFCPTGACTTRC
32
36.8%
NZ_BMFU01000012.1:
Lanthipeptides: IEW26_RS25390_lanthipeptide
2
DVHAQTTWPCA--------TVGVSVALCPTTKCTSQC
30
+V A ++WPCA T+ S CP+T C+S+C
2
EVQAASSWPCAIVPPVVIWTITDSANSCPSTACSSRC
38
36.7%
NZ_AP026721.1:
Lanthipeptides: PO855_RS02215_lanthipeptide
1
GDVHAQTTWPCATVGVSVALCPTTK
25
GDV A+TT C T+G+ V + K
1
GDVQAETTPACFTIGLGVGALFSAK
25
36.7%
NZ_BJTV01000004.1:
Lanthipeptides: TNCT1_RS35800_lanthipeptide
18
VALCPTTKCTSQC
30
VA CPTTKCTS C
1
VAFCPTTKCTSAC
13
36.7%
NZ_CP016076.1:
Lanthipeptides: UA74_RS09535_lanthipeptide
7
TTWPCATVGVSVALCPTTK
25
TTWPC + VS+A C TK
1
TTWPCFGITVSIAACQGTK
19
36.7%
NZ_CP039292.1:
Lanthipeptides: E4J16_RS14990_lanthipeptide
7
TTWPCATVGVSVALCPTTKCTSQC
30
++WPC +G++ +CPT CTS+C
5
SSWPCG-IGITTTICPTAVCTSKC
27
36.7%
NZ_CP050134.2:
Lanthipeptides: HBA49_RS00775_lanthipeptide
8
TWPCATVGVSVALCPTTKCTSQC
30
T P + +S+ALCPTT+C+ +C
1
THPSTLIPISIALCPTTRCSRRC
23
36.7%
NZ_CP084530.1:
Lanthipeptides: LDO05_RS02090_lanthipeptide
7
TTWPCATVGVSVALCPTTKCTSQC
30
++W C S A CP+T CTS+C
7
SSWICGVA--SAAFCPSTACTSKC
28
36.7%
NZ_JACDUU010000003.1:
Lanthipeptides: HNQ85_RS08030_lanthipeptide
1
GDVHAQTTWPCA-TVGVSVAL
20
GDV +TT PCA T+GV++ +
1
GDVQPETTTPCAYTIGVTIGI
21
36.7%
NZ_JH791802.1:
Lanthipeptides: IKS_RS03655_lanthipeptide
1
GDVHAQTTWPCATVGVSVA
19
GDV A+TT C TVG+ V
1
GDVQAETTPVCFTVGLGVG
19
35.5%
NZ_LT985747.1:
Lanthipeptides: C8268_RS00150_lanthipeptide
7
TTWPCATVGVSVALCPTTKCTSQC
30
++W C V + ALCP+T CT C
10
SSWICGFV--TAALCPSTACTGDC
31
35.3%
NZ_NUML01000015.1:
Lanthipeptides: COD66_RS20280_lanthipeptide
1
GDVHAQTTWPCAT---VGVSVALCPTTKCTSQC
30
GD++ +T T V ++ LCP+ CTS+C
1
GDMNPETIPATPTPILVNLTKELCPSIPCTSRC
33
34.9%
NZ_JAASAG010000001.1:
Lanthipeptides: HCC61_RS01465_lanthipeptide
9
WPCATVGVS-VALCPTTKCTSQC
30
W ATV ++ A+CPTTKCTSQC
21
WCVATVTLATAAICPTTKCTSQC
43
34.9%
NZ_QLLX01000002.1:
Lanthipeptides: K378_RS30040_lanthipeptide
9
WPCATVGVS-VALCPTTKCTSQC
30
W ATV ++ A+CPTTKCTSQC
21
WCIATVTLATAAICPTTKCTSQC
43
34.2%
NZ_JACHKG010000014.1:
Lanthipeptides: HNR77_RS17300_lanthipeptide
2
DVHAQTTWPCA--------TVGVSVALCPTTKCTSQC
30
+V ++WPCA T+ S CP+T C+S+C
2
EVQVASSWPCAIVPPVVIWTITDSANSCPSTACSSRC
38
34.2%
NZ_JAHXMW010000012.1:
Lanthipeptides: KZX51_RS23840_lanthipeptide
2
DVHAQTTWPCA--------TVGVSVALCPTTKCTSQC
30
+V ++WPCA T+ S CP+T C+S+C
2
EVQVASSWPCAIVPPVLIWTITDSANSCPSTACSSRC
38
33.3%
NZ_BOSN01000007.1:
Lanthipeptides: KJS43_RS18000_lanthipeptide
10
PCATVGVSVALCPTTKCTS
28
P + VS+A+CPTTKC S
8
PATIIPVSLAICPTTKCAS
26
33.3%
NZ_CP011974.1:
Lanthipeptides: BEH_RS02100_lanthipeptide
1
GDVHAQTTWPCATVGVSVA
19
GDV A+TT C T+G+ V
1
GDVQAETTPVCFTIGLGVG
19
33.3%
NZ_CP025249.1:
Lanthipeptides: CWT12_RS00390_lanthipeptide
7
TTWPCATVGVSVALCPTTKCTSQC
30
++WPC +G++ +CPT C+S+C
5
SSWPCG-IGITTTVCPTAACSSKC
27
33.3%
NZ_JH791802.1:
Lanthipeptides: IKS_RS03660_lanthipeptide
1
GDVHAQTTWPCATVGVSVA
19
GDV A+TT C TVG+ +
1
GDVQAETTPVCFTVGLGIG
19
33.3%
NZ_KE384107.1:
Lanthipeptides: G586_RS26715_lanthipeptide
14
VGVSVALCPTTKCTSQC
30
+ S A CPT KCTS+C
14
IAASTAFCPTIKCTSKC
30
33.3%
NZ_MJEJ02000054.1:
Lanthipeptides: BH683_RS28810_lanthipeptide
16
VSVALCPTTKCT
27
+SVALCPT KCT
12
LSVALCPTFKCT
23
33.3%
NZ_MLKL01000042.1:
Lanthipeptides: BKK45_RS27415_lanthipeptide
1
GDVHAQTTWPCATVGVSVA-----LCPTTKCTSQ
29
GDV+ +T TV + + LCPT CT Q
1
GDVNPETMPGPVTVTIVIPVFTNKLCPTVPCTRQ
34
33.3%
NZ_NTSR01000029.1:
Lanthipeptides: CN358_RS25165_lanthipeptide
2
DVHAQTTWPCATVGVSVAL-----------CPTTKCTSQC
30
+V+ +TT PCA G +V + CPT+ C+S+C
2
EVNPRTTVPCAVGGATVGITIYTFDRSHQSCPTSACSSRC
41
32.4%
NZ_CP084663.1:
Lanthipeptides: LA357_RS19865_lanthipeptide
2
DVHAQTTWPCATVGVSV
18
DV AQTT A+V VSV
1
DVEAQTTPTIASVLVSV
17
32.4%
NZ_WIXN01000006.1:
Lanthipeptides: GHD25_RS06900_lanthipeptide
8
TWPCATVGVSVALCPTTKCTS
28
T P + VS+A+CPTT C S
7
THPTTIIPVSLAVCPTTTCRS
27
30.3%
NZ_CP070496.1:
Lanthipeptides: JQS30_RS16095_lanthipeptide
7
TTWPCATVGVSVALCPTTK
25
TTW CATV ++V +C T
1
TTWGCATVTLTVTVCSPTN
19
30.2%
NZ_BJTV01000004.1:
Lanthipeptides: TNCT1_RS35805_lanthipeptide
13
TVGVSVALCPTTKCTSQC
30
TV SVA CPT KCTS C
26
TVAASVAFCPTIKCTSAC
43
30.0%
NZ_CP040417.1:
Lanthipeptides: FE328_RS09035_lanthipeptide
14
VGVSVALCPTTKCTS
28
V +S+A+CP+TKC S
7
VPISLAICPSTKCAS
21
30.0%
NZ_CP063142.1:
Lanthipeptides: HPB58_RS12640_lanthipeptide
1
GDVHAQTTWPCATV
14
DV QTTWPC V
1
SDVSPQTTWPCVVV
14
30.0%
NZ_FOBE01000018.1:
Lanthipeptides: BMW61_RS21935_lanthipeptide
13
TVGVSVALCPTTKCTSQC
30
T+ S A CP+ KC+S+C
13
TIAASTAFCPSIKCSSKC
30
30.0%
NZ_JAOVZP010000016.1:
Lanthipeptides: OF830_RS26680_lanthipeptide
1
GDVHAQTTWPCATVGVS
17
GDV +TT C T+GV
1
GDVSPETTPLCITIGVG
17
30.0%
NZ_KE384533.1:
Lanthipeptides: K329_RS31315_lanthipeptide
16
VSVALCPTTKCTSQC
30
VS CPTT CT +C
13
VSTNTCPTTSCTDEC
27
30.0%
NZ_KZ845663.1:
Lanthipeptides: DL897_RS01070_lanthipeptide
1
GDVHAQTTWPCATVGVSVALC
21
D QTT PC + SV +C
1
SDTQPQTTVPCLAITFSVFMC
21
29.4%
NZ_CP101913.1:
Lanthipeptides: NP440_RS09140_lanthipeptide
10
PCATVGVSVALCPTTKCTS
28
P T+ +S A+CPTT+C S
8
PTVTIPISAAICPTTQCAS
26
29.4%
NZ_KQ040792.1:
Lanthipeptides: WH45_RS23705_lanthipeptide
10
PCATVGVSVALCPTTKCTS
28
P + VS+A+CPTT+C S
9
PATIIPVSLAICPTTRCAS
27
28.9%
NZ_CP017953.1:
Lanthipeptides: BAMY_RS16390_lanthipeptide
13
TVGVSVALCPTTKCTSQC
30
TV +S A CPT+ CT QC
19
TVTLSAASCPTSACTKQC
36
28.9%
NZ_JALIRS010000003.1:
Lanthipeptides: MOK21_RS07280_lanthipeptide
1
GDVHAQTTWPCA------TVGVSVALCPTTKCTSQC
30
G+V+ +++W C T+ S+ CP+T C+++C
1
GEVNPRSSWGCVIDVTIWTITDSMNSCPSTACSTRC
36
28.9%
NZ_JALIRS010000003.1:
Lanthipeptides: MOK21_RS07275_lanthipeptide
1
GDVHAQTTWPCA------TVGVSVALCPTTKCTSQC
30
G+V+ +++W C T+ S+ CP+T C+++C
1
GEVNPRSSWGCVVQVTIYTISDSMNSCPSTACSTRC
36
28.6%
NZ_CP085411.1:
Lanthipeptides: LIT28_RS29915_lanthipeptide
15
GVSVALCPTTKCTSQC
30
G ++++CPTTKCTS+C
20
GATISVCPTTKCTSRC
35
28.6%
NZ_JAMDLZ010000027.1:
Lanthipeptides: M5W82_RS15520_lanthipeptide
13
TVGVSVALCPTTKCTS
28
T+ +S+A CPTTKC S
13
TIPISLAGCPTTKCAS
28
28.6%
NZ_QNUC01000031.1:
Lanthipeptides: DN396_RS23045_lanthipeptide
15
GVSVALCPTTKCTSQC
30
G ++++CPTTKCTS+C
20
GATISICPTTKCTSRC
35
28.2%
NZ_WHOM01000078.1:
Lanthipeptides: GCN81_RS29290_lanthipeptide
14
VGVSVAL---CPTTKCTSQC
30
VG S AL CPT+ CT +C
20
VGASAALQGGCPTSGCTKRC
39
28.1%
NZ_CP063142.1:
Lanthipeptides: HPB58_RS21455_lanthipeptide
13
TVGVSVALCPTTKCTS
28
T+ +S+A CPTT+C S
10
TIPISLAACPTTQCAS
25
28.1%
NZ_JANIOB010000033.1:
Lanthipeptides: NQ113_RS28015_lanthipeptide
19
ALCPTTKCTSQC
30
ALCPT +CTS+C
21
ALCPTPRCTSRC
32
27.9%
NZ_BNBV01000031.1:
Lanthipeptides: IE286_RS22990_lanthipeptide
13
TVGVSVALCPTTKCTSQC
30
TV S A CPTTKCT+ C
26
TVAASAAFCPTTKCTNDC
43
27.8%
NZ_CP047645.1:
Lanthipeptides: GSN02_RS17435_lanthipeptide
13
TVGVSVALCPTTKCTSQC
30
TV +S A CPT+ CT+ C
17
TVTLSAASCPTSACTNLC
34
27.3%
NZ_CP102975.1:
Lanthipeptides: NW953_RS00175_lanthipeptide
14
VGVSVALCPTTKCTSQC
30
V S A CPT C+S+C
12
VAASTAQCPTLACSSRC
28
27.3%
NZ_DS999644.1:
Lanthipeptides: SSGG_RS13165_lanthipeptide
7
TTWPCATVGVSVALC
21
TTW CATV ++V +C
1
TTWACATVTLTVTVC
15
27.0%
NZ_CM001792.1:
Lanthipeptides: C794_RS17975_lanthipeptide
14
VGVSVALCPTTKCTSQC
30
V +S+A CPT+ CTS C
18
VAISLAFCPTSACTSDC
34
26.7%
NZ_BQME02000001.1:
Lanthipeptides: MFF31_RS04090_lanthipeptide
14
VGVSVALCPTTKCTS
28
+ +S+A CPTT+C S
9
IPISLAACPTTRCAS
23
26.7%
NZ_FQZK01000006.1:
Lanthipeptides: BUE45_RS13105_lanthipeptide
21
CPTTKCTSQC
30
CPTT CTS+C
19
CPTTVCTSRC
28
26.7%
NZ_JAHHYI010000012.1:
Lanthipeptides: KM925_RS25405_lanthipeptide
1
GDVHAQTTWPCATVGVSVAL
20
GDV +TT C G++V +
1
GDVQPETTPACVGAGITVGI
20
26.7%
NZ_NTSF01000026.1:
Lanthipeptides: CN325_RS31015_lanthipeptide
19
ALCPTTKCTSQC
30
A CPT+KCT++C
1
AFCPTSKCTTRC
12
26.5%
NZ_KV917378.1:
Lanthipeptides: BK581_RS20095_lanthipeptide
13
TVGVSVALCPTTKCTS
28
T+ +S A CPTT+C S
12
TIPISAAACPTTQCAS
27
25.9%
NC_016582.1:
Lanthipeptides: SBI_RS34370_lanthipeptide
14
VGVSVALCPTTKCTSQC
30
VGVS A CPTTKCTS+C
38
VGVSAAFCPTTKCTSRC
54
25.0%
NC_023073.1:
Lanthipeptides: U722_RS19995_lanthipeptide
17
SVALCPTTKCTS
28
S+A CPTTKC S
18
SLAGCPTTKCAS
29
24.2%
NZ_BMTW01000001.1:
Lanthipeptides: IE134_RS03420_lanthipeptide
7
TTWPCATVGVSVALC
21
TTW CAT+ ++V +C
1
TTWACATITLTVTVC
15
23.8%
NZ_BMRY01000003.1:
Lanthipeptides: IE140_RS12360_lanthipeptide
14
VGVSVAL---CPTTKCTSQC
30
VG S A+ CPT+ CT +C
23
VGASAAMQGGCPTSGCTKRC
42
23.3%
NZ_BIFH01000022.1:
Lanthipeptides: EMA17_RS52585_lanthipeptide
16
VSVALCPTTKCTSQC
30
++ +CPTT C+S+C
14
ITATMCPTTACSSKC
28
22.6%
NZ_NVJC01000007.1:
Lanthipeptides: COM38_RS07270_lanthipeptide
15
GVSVALCPTTKC
26
G ++++CPTTKC
20
GATISVCPTTKC
31
22.2%
NZ_CP047419.1:
Lanthipeptides: GTU71_RS12785_lanthipeptide
17
SVALCPTTKCTSQC
30
S LCPT CT +C
23
SSGLCPTFSCTGEC
36
20.0%
NZ_CP036019.1:
Lanthipeptides: EXW52_RS27200_lanthipeptide
8
TWPCATVGVSVALCPTTK
25
T+ C G SV LCPT +
24
TYNCG--GKSVGLCPTNR
39
19.6%
NZ_JAJAGO010000028.1:
Lanthipeptides: LHJ74_RS33595_lanthipeptide
7
TTWPCATVGVSVALCPTTKCTSQC
30
++W C T ++++CPT+ C+S+C
24
SSWTCITAA-TISICPTSACSSKC
46
18.6%
NZ_CP016795.1:
Lanthipeptides: BC342_RS37680_lanthipeptide
20
LCPTTKCTSQC
30
CPTTKCT +C
33
FCPTTKCTKEC
43
18.2%
NZ_FPCC01000026.1:
Lanthipeptides: BM377_RS12925_lanthipeptide
1
GDVHAQTTWPCATV
14
GDV A+TT P + V
17
GDVEAETTVPLSVV
30
MIBiG 3.1 matches for BH0453
37.8%
BGC0001229 (SBI_06989):
Lanthipeptide: SBI-06990 A1 or SBI-06989 A2
14
VGVSVALCPTTKCTSQC
30
VGVS A CPTTKCTS+C
21
VGVSAAFCPTTKCTSRC
37
BH0454
Leader:
MTNLLKEWKMPLERTHNNSNPAGDIFQELEDQDILAG
Core:
VNGACAWYNISCRLGNKGAYCTLTVECMPSCN
Core with dehydrations:
VNGACysAWYNIDhaCysRLGNKGAYCysDhbLDhbVECysMPDhaCysN
antiSMASH-DB 4.0 matches for BH0454
100.0%
NC_002570.2:
Lanthipeptides: AYT26_RS02480_lanthipeptide
1
VNGACAWYNISCRLGNKGAYCTLTVECMPSCN
32
VNGACAWYNISCRLGNKGAYCTLTVECMPSCN
1
VNGACAWYNISCRLGNKGAYCTLTVECMPSCN
32
71.9%
NZ_CP006058.1:
Lanthipeptides: BAMY6639_RS13800_lanthipeptide
5
CAWYNISCRLGNKGAYCTLTVECMPSCN
32
CAWY+ISC+LGNKGA+CTLTVEC SCN
1
CAWYDISCKLGNKGAWCTLTVECQSSCN
28
68.8%
NZ_CP063276.1:
Lanthipeptides: IM743_RS02795_lanthipeptide
5
CAWYNISCRLGNKGAYCTLTVECMPSCN
32
CAWY++SCRLGNKGA+CTLTVEC +CN
1
CAWYDVSCRLGNKGAWCTLTVECQNNCN
28
with 101 more sequence matches
62.5%
NC_021362.1:
Lanthipeptides: BALI_RS00925_lanthipeptide
5
CAWYNISCRLGNKGAYCTLTVECMPSCN
32
C WYNISC+LGNKG +CTLT EC SC
1
CEWYNISCQLGNKGQWCTLTKECQRSCK
28
62.5%
NZ_CP034118.1:
Lanthipeptides: EG886_RS06310_lanthipeptide
5
CAWYNISCRLGNKGAYCTLTVECMPSCN
32
C W+NISC LGN G +CTLT EC PSCN
1
CDWWNISCHLGNTGQFCTLTKECQPSCN
28
59.4%
NZ_CP034118.1:
Lanthipeptides: EG886_RS06305_lanthipeptide
5
CAWYNISCRLGNKGAYCTLTVECMPSCN
32
C W+NISC LGN G +CTLT EC P+CN
1
CDWWNISCHLGNTGRFCTLTKECQPNCN
28
56.2%
NC_018499.1:
Lanthipeptides: BCK_RS27860_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSCN
32
+S LGNKG YCTLT ECMPSCN
10
LSSWLGNKGGYCTLTKECMPSCN
32
56.2%
NZ_NTSF01000026.1:
Lanthipeptides: CN325_RS21845_lanthipeptide
5
CAWYNISCRLGNKGAYCTLTVECMPSCN
32
C+W+N+SC LGN G YCT + ECMP+CN
2
CSWWNVSCHLGNDGKYCTASKECMPTCN
29
53.1%
NZ_CP015591.1:
Lanthipeptides: A7A70_RS27565_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSCN
32
+S LGN G YCTLT ECMPSCN
10
LSSWLGNNGGYCTLTKECMPSCN
32
53.1%
NZ_CP036019.1:
Lanthipeptides: EXW52_RS27215_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSCN
32
+S LGNKG YCTLT ECM SCN
10
LSSWLGNKGGYCTLTKECMSSCN
32
53.1%
NZ_LT630004.1:
Lanthipeptides: BQ5796_RS17475_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSCN
32
+S LGN G +CTLTVECMPSCN
2
LSSLLGNDGKFCTLTVECMPSCN
24
53.1%
NZ_NTSF01000026.1:
Lanthipeptides: CN325_RS21835_lanthipeptide
5
CAWYNISCRLGNKGAYCTLTVECMPSC
31
C ++NISC LGN G+ CTLT EC P+C
2
CNFWNISCHLGNDGSVCTLTKECRPAC
28
50.0%
NZ_CP017762.1:
Lanthipeptides: BKP57_RS02100_lanthipeptide
5
CAWYNISCRLGNKGAYCTLTVECMPSCN
32
C WYN+SC LGN G CT + EC CN
2
CPWYNLSCHLGNDGKICTFSHECTGGCN
29
50.0%
NZ_CP036016.1:
Lanthipeptides: allorf_075467_075682_lanthipeptide
5
CAWYNISCRLGNKGAYCTLTVECMPSC
31
C W+++SC LGN G+ CTL+VEC P+C
2
CTWWDLSCHLGNDGSTCTLSVECRPAC
28
50.0%
NZ_CP102975.1:
Lanthipeptides: NW953_RS00170_lanthipeptide
3
GACAWYNISCRLGNKGAYCTLTVECMPSCN
32
G C+W+N+SC LGN G CT++ EC CN
1
GKCSWWNLSCHLGNNGKLCTVSHECAAGCN
30
50.0%
NZ_FOBE01000018.1:
Lanthipeptides: BMW61_RS13085_lanthipeptide
7
WYN-ISCRLGNKGAYCTLTVECMPSCN
32
WY+ +S LGN+G+YCTLT EC CN
2
WYSEMSAALGNRGSYCTLTKECQACCN
28
50.0%
NZ_LR134483.1:
Lanthipeptides: EL241_RS01720_lanthipeptide
7
WYNISCRLGNKGAYCTLTVECMPSCN
32
W+N+S LGNKG CTLT EC CN
1
WWNVSKNLGNKGRICTLTKECQSMCN
26
46.9%
NC_006322.1:
Lanthipeptides: BLI_RS20295_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSCN
32
+S LGN G CT+T ECMPSCN
10
LSKPLGNNGYLCTVTKECMPSCN
32
46.9%
NZ_BMMP01000005.1:
Lanthipeptides: IEY56_RS28370_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S LGN G +CTLTVEC P+CN
6
FSLSDVLGNTGGWCTLTVECQPNCN
30
46.9%
NZ_CP050134.2:
Lanthipeptides: HBA49_RS00770_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSCN
32
+S LGN G +CT+T ECMPSCN
1
LSRLLGNNGRWCTITKECMPSCN
23
46.9%
NZ_KE384107.1:
Lanthipeptides: G586_RS23925_lanthipeptide
6
AWY-NISCRLGNKGAYCTLTVECMPSCN
32
WY ++S LGN+G+YCT+T EC CN
1
GWYADLSASLGNRGSYCTITKECQACCN
28
46.9%
NZ_LT985747.1:
Lanthipeptides: C8268_RS00165_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+ +S LGNKG +CTLT EC SCN
6
FTLSDYLGNKGGWCTLTKECQRSCN
30
44.4%
NZ_CP009288.1:
Lanthipeptides: PDUR_RS25150_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSCN
32
IS LGN G CT T ECMPSCN
14
ISMTLGNNGWVCTATKECMPSCN
36
44.1%
NZ_CP042598.1:
Lanthipeptides: FUT28_RS13825_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S LGN G +CT T ECMPSCN
10
FSLSDYLGNTGGWCTATKECMPSCN
34
44.1%
NZ_JADPDT010000005.1:
Lanthipeptides: I4V19_RS09885_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S LGN G +CT T ECMPSCN
10
FSLSDFLGNTGGWCTATKECMPSCN
34
43.8%
NZ_AKXV01000031.1:
Lanthipeptides: Y19_RS0109895_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S LGN+G +CTLT EC P+CN
6
FSLSDFLGNQGGWCTLTKECQPNCN
30
43.8%
NZ_BNBV01000031.1:
Lanthipeptides: IE286_RS22995_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S LGN G +CTLT EC P+CN
6
FSLSDALGNSGGWCTLTKECQPNCN
30
43.8%
NZ_CKMQ01000043.1:
Lanthipeptides: AE832_RS11585_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSC
31
IS LGNKGA CT T+EC +C
8
ISEALGNKGAVCTGTIECQNNC
29
43.8%
NZ_CP043405.1:
Lanthipeptides: FY406_RS04355_lanthipeptide
11
SCRLGNKGAYCTLTVECMPSCN
32
S LGNKG CT+TVECM +C
11
SIVLGNKGYICTVTVECMRNCQ
32
43.8%
NZ_CP047419.1:
Lanthipeptides: GTU71_RS12805_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+ +S LGN+G +CTLTVEC P+C
6
FTLSNVLGNQGGWCTLTVECQPNC
29
43.8%
NZ_CP084530.1:
Lanthipeptides: LDO05_RS02075_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+ +S LGN G +CTLT EC SCN
6
FTLSNYLGNNGGWCTLTKECQRSCN
30
43.8%
NZ_CP107567.1:
Lanthipeptides: OGH68_RS19760_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S LGN+G +CTLT EC P+CN
6
FSLSDWLGNQGGWCTLTKECQPNCN
30
43.8%
NZ_JAASAG010000001.1:
Lanthipeptides: HCC61_RS30395_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S L N G +CTLTVEC P+CN
6
FSLSDALTNTGGWCTLTVECQPNCN
30
43.8%
NZ_KV795763.1:
Lanthipeptides: allorf_248182_248337_lanthipeptide
6
AWYNISCRLGNKGAYCTLTVECMPSCN
32
WY S +GN+G CT+TVECM C
5
GWY--SKVIGNRGRVCTVTVECMSVCQ
29
43.8%
NZ_LR134483.1:
Lanthipeptides: EL241_RS01725_lanthipeptide
6
AWYNISCRLGNKGAYCTLTVECMPSCN
32
W ++S LGNKG CTLT EC C
2
GWKDLSKSLGNKGYVCTLTKECQKLCR
28
43.8%
NZ_QLLX01000002.1:
Lanthipeptides: K378_RS05175_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S L N+G +CTLTVEC P+CN
6
FSLSDALTNQGGWCTLTVECQPNCN
30
42.4%
NC_018089.1:
Lanthipeptides: SMUGS5_RS08725_lanthipeptide
11
SCRLGNKGAYCTLTVECMPSCN
32
S LGNKG CT+TVECM +C+
11
SIVLGNKGYICTVTVECMRNCS
32
42.4%
NZ_KL997439.1:
Lanthipeptides: IQ62_RS47105_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+ +S +LG+KG CT T EC PSCN
9
FTLSAQLGDKGDCCTATKECQPSCN
33
42.1%
NZ_CP013862.1:
Lanthipeptides: AOX59_RS09360_lanthipeptide
5
CAWYNISCRLGNKGAYCTLTVECMPSCN
32
C W IS +GN G CT TVEC P+CN
13
CHW--ISPAMGNDGHLCTATVECQPNCN
38
41.7%
NZ_CP009280.1:
Lanthipeptides: P40081_RS01820_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSCN
32
IS LGN G CT + ECMPSCN
14
ISRGLGNDGWVCTWSKECMPSCN
36
40.6%
NZ_BJTV01000004.1:
Lanthipeptides: TNCT1_RS10200_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S LGN G +CTLT EC +CN
6
FSLSDALGNHGGWCTLTKECQANCN
30
40.6%
NZ_BLIS01000009.1:
Lanthipeptides: GVO03_RS04820_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+++S GNKG +CTLT ECM C
6
FSLSDYWGNKGNWCTLTHECMNWC
29
40.6%
NZ_BNCA01000011.1:
Lanthipeptides: IE314_RS15865_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S +GN G +CTLT EC P+CN
6
FSLSDAVGNHGGWCTLTKECQPNCN
30
40.6%
NZ_CP016795.1:
Lanthipeptides: BC342_RS18360_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S LGN G +CTLT EC P+C+
6
FSLSDALGNHGGWCTLTKECQPNCS
30
40.6%
NZ_CP025249.1:
Lanthipeptides: CWT12_RS00385_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSCN
32
+S +LGN G CTLT EC CN
5
LSRKLGNTGYVCTLTKECQRMCN
27
40.6%
NZ_CP043317.1:
Lanthipeptides: FYC74_RS17680_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S LGN G +CTLT EC P+C+
6
FSLSDSLGNHGGWCTLTKECQPNCS
30
40.0%
NZ_BIFH01000022.1:
Lanthipeptides: EMA17_RS23445_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSCN
32
S LGN G +CTLT EC SCN
13
FSNDLGNHGNWCTLTKECQRSCN
35
39.4%
NZ_GG657757.1:
Lanthipeptides: SSQG_RS20730_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S GN G CTLT EC SCN
9
FSLSGIFGNDGDCCTLTKECQASCN
33
37.5%
NZ_AP026714.1:
Lanthipeptides: PO853_RS06515_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+++S GNKG +CT T ECM C
6
FSLSDYWGNKGNWCTATHECMGWC
29
37.5%
NZ_CP027862.1:
Lanthipeptides: allorf_0097945_0098112_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S GN+G +CTLT ECM C
6
FSLSDYWGNRGYWCTLTHECMSWCK
30
37.5%
NZ_CP061868.1:
Lanthipeptides: IE339_RS06330_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+++S GNKG +CT T ECM C
6
FSLSDYWGNKGGWCTATHECMSWC
29
37.5%
NZ_GG657754.1:
Lanthipeptides: SSOG_RS49055_lanthipeptide
6
AWYNISCRLGNKGAYCTLTVECMPSC
31
A Y +S +GN G +CT T+EC +C
5
AEYVVSFVMGNLGNFCTATLECQKNC
30
37.5%
NZ_JAJAGO010000028.1:
Lanthipeptides: LHJ74_RS33590_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S GN G +CTLT EC +CN
6
FSLSDAAGNDGWWCTLTKECQRTCN
30
35.6%
NZ_JACEIQ010000001.1:
Lanthipeptides: H1191_RS00080_lanthipeptide
15
GNKGAYCTLTVECMPSCN
32
GN G YCTLTVECMPSCN
28
GNDGWYCTLTVECMPSCN
45
35.3%
NZ_BQXZ01000001.1:
Lanthipeptides: OCU69_RS05000_lanthipeptide
2
NGACAWYNISCRLGNKGAYCTLTVECMPSCN
32
+G +S +GNKG+ CT T+EC +C+
3
SGGTISITLSVYMGNKGSVCTWTIECQSNCS
33
35.1%
NZ_QKTG01000020.1:
Lanthipeptides: DEI99_RS16920_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
Y +S LGN G +CT TVEC +C
13
YGVSWALGNDGNFCTATVECQSNC
36
34.4%
NZ_CACZYW010000004.1:
Lanthipeptides: HUF10_RS02825_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+++S GN G +CTL+ ECM C
6
FSLSDYWGNNGNWCTLSHECMAWC
29
34.4%
NZ_CP016767.1:
Lanthipeptides: BCV50_RS13410_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+++S GNKG +CT++ ECM C
6
FSLSDYWGNKGGWCTVSKECMAWC
29
34.4%
NZ_CP030280.1:
Lanthipeptides: DQQ01_RS07655_lanthipeptide
15
GNKGAYCTLTVECMPSCN
32
GN G C++TVECM CN
7
GNDGYLCSVTVECMIICN
24
34.4%
NZ_CP030280.1:
Lanthipeptides: DQQ01_RS07650_lanthipeptide
15
GNKGAYCTLTVECMPSCN
32
GN G C++TVECM CN
7
GNDGYLCSVTVECMVICN
24
34.4%
NZ_CP034414.1:
Lanthipeptides: EI692_RS18440_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+++S GNKG +CT++ ECM C
6
FSLSDYWGNKGGWCTISHECMSWC
29
34.4%
NZ_CP051884.1:
Lanthipeptides: HGK68_RS15125_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+++S GN G CT+T ECM C
6
FSLSDYWGNNGWLCTITHECMSWC
29
34.4%
NZ_KE384533.1:
Lanthipeptides: K329_RS0118200_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+++S GN G +CTL+ ECM C
6
FSLSDAYGNTGGWCTLSQECMSWC
29
34.4%
NZ_MJEJ02000054.1:
Lanthipeptides: BH683_RS28205_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+ +S LGN G +CTLT E +C
6
FTLSDFLGNDGGWCTLTKESQNNC
29
34.4%
NZ_PCGR01000003.1:
Lanthipeptides: CQS04_RS09620_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+++S GN G +CT T ECM C
6
FSLSDYWGNNGNWCTATHECMSWC
29
34.4%
NZ_QGEE01000020.1:
Lanthipeptides: DKP74_RS06160_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+++S GN+G +CTL+ ECM C
6
FSLSDYWGNRGNWCTLSHECMAWC
29
34.2%
NZ_CM000756.1:
Lanthipeptides: BTHUR0011_RS34475_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSC
31
IS GNKG CT TVEC+ +C
15
ISETFGNKGKVCTYTVECVNNC
36
33.3%
NZ_JALGRP010000007.1:
Lanthipeptides: MT347_RS12955_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
Y +S GN G CT TVEC +CN
15
YGVSWVAGNNGQVCTATVECQNNCN
39
32.5%
NZ_JALIRS010000003.1:
Lanthipeptides: MOK21_RS07255_lanthipeptide
14
LGNKGAYCTLTVECMPSCN
32
LGN G CTLTVEC CN
22
LGNPGHVCTLTVECQKKCN
40
32.4%
NZ_BCEY01000006.1:
Lanthipeptides: GOZ53_RS01290_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSCN
32
IS LGN G CT T EC +C
15
ISFALGNDGWICTWTAECQATCK
37
32.4%
NZ_CP017953.1:
Lanthipeptides: BAMY_RS16400_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSC
31
+S LGNKG CT T EC +C
16
VSEVLGNKGKVCTGTKECQGTC
37
32.4%
NZ_BMVL01000013.1:
Lanthipeptides: IE257_RS28650_lanthipeptide
14
LGNKGAYCTLTVECMPSCN
32
LGN G CT+TVEC +C
15
LGNNGHLCTVTVECQKNCQ
33
31.7%
NZ_NTSR01000029.1:
Lanthipeptides: CN358_RS25180_lanthipeptide
7
WYNISCRLGNKGAYCTLTVECMPSCN
32
+ +S LGN G CT TVEC +CN
16
YIKLSIGLGNNGYICTYTVECQKNCN
41
31.6%
NZ_BMRY01000003.1:
Lanthipeptides: IE140_RS12370_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
Y S LGN G +CT T EC +C
14
YGASYVLGNNGNFCTATAECQNNC
37
31.6%
NZ_WHOM01000078.1:
Lanthipeptides: GCN81_RS29300_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
Y S LGN G +CT T EC +C
14
YGASYVLGNNGNFCTATAECQSNC
37
31.4%
NZ_CP092836.1:
Lanthipeptides: MLD62_RS30280_lanthipeptide
8
YNISCRL-------GNKGAYCTLTVECM
28
YN+S + GN G +CT + ECM
1
YNLSAAIADAAGLKGNYGKFCTYSAECM
28
31.2%
NC_016582.1:
Lanthipeptides: SBI_RS34375_lanthipeptide
15
GNKGAYCTLTVECMPSCN
32
G G +CTL+ EC P+CN
3
GGFGLFCTLSKECQPNCN
20
31.2%
NZ_BQME02000001.1:
Lanthipeptides: MFF31_RS04105_lanthipeptide
15
GNKGAYCTLTVEC
27
GN G YCTLT EC
9
GNDGKYCTLTWEC
21
31.2%
NZ_CP061033.1:
Lanthipeptides: IAU67_RS09320_lanthipeptide
14
LGNKGAYCTLTVECMPSCN
32
LGN+G +CT T+EC +C
4
LGNEGNFCTGTIECQKTCQ
22
31.2%
NZ_FMPI01000012.1:
Lanthipeptides: BJR39_RS08305_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+++S GN G +CT + ECM C
6
FSLSDYWGNNGNWCTASHECMSWC
29
31.2%
NZ_FNHR01000005.1:
Lanthipeptides: BLQ37_RS05590_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+++S +GN G +CT++ ECM C
6
FSLSDYMGNNGNWCTISHECMAWC
29
31.2%
NZ_MIFN01000022.1:
Lanthipeptides: BHL26_RS15350_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+++S GN G++C+L+ ECM C
6
FSLSDYWGNDGSWCSLSHECMSWC
29
31.2%
NZ_NUIO01000031.1:
Lanthipeptides: CN977_RS23160_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+++S GN G++CT T EC+ C
6
FSLSDYWGNDGSWCTATHECLSWC
29
31.0%
NZ_BMFU01000012.1:
Lanthipeptides: IEW26_RS25375_lanthipeptide
14
LGNKGAYCTLTVECMPSCN
32
+GN G CTLTVEC SCN
24
MGNPGHVCTLTVECQKSCN
42
30.6%
NC_017299.1:
Lanthipeptides: H04402_RS03105_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSCN
32
+S +GN G CT TVEC +C+
11
LSVYMGNDGKVCTWTVECQNNCS
33
30.6%
NZ_JAENHN010000066.1:
Lanthipeptides: JHL18_RS24425_lanthipeptide
14
LGNKGAYCTLTVECMPSCN
32
LGN+G C+LT EC CN
6
LGNQGKKCSLTRECQRLCN
24
30.6%
NZ_JAGKQT010000007.1:
Lanthipeptides: J2M30_RS09860_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSC
31
+S +GN G CT TVEC+ +C
14
VSHFVGNDGKVCTYTVECVNNC
35
29.7%
NC_015215.1:
Lanthipeptides: SGGBAA2069_RS00705_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSCN
32
+S LGN G CT T EC +C
15
LSIGLGNDGWVCTWTAECQATCR
37
29.7%
NZ_CP047645.1:
Lanthipeptides: GSN02_RS17445_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSC
31
+S GNKG CT T EC +C
16
VSEVFGNKGKVCTGTKECQGTC
37
29.4%
NZ_CP040417.1:
Lanthipeptides: FE328_RS05345_lanthipeptide
5
CAWYNISCRLGNKGAYCTLTVECMPSCN
32
C W+N+SC LGN G CT + EC CN
23
CPWWNLSCHLGNDGKICTYSHECTAGCN
50
29.4%
NZ_WITJ01000001.1:
Lanthipeptides: GHI93_RS00065_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSC
31
++ LGN G CT T EC +C
12
VTLALGNNGYVCTWTHECQANC
33
28.9%
NZ_JAQFWW010000002.1:
Lanthipeptides: PDT38_RS11330_lanthipeptide
11
SCRLGNKGAYCTLTVECMPSC
31
S +G+KG CT TVEC +C
16
SIMIGDKGQVCTGTVECQNNC
36
28.9%
NZ_LT575476.1:
Lanthipeptides: BN6628_RS02285_lanthipeptide
14
LGNKGAYCTLTVECMPSCN
32
LG+KG CT TVEC+ +C
19
LGDKGQVCTATVECINNCR
37
28.1%
NZ_BOSN01000007.1:
Lanthipeptides: KJS43_RS18005_lanthipeptide
15
GNKGAYCTLTVEC
27
GN G YCT+T EC
10
GNDGKYCTITWEC
22
28.1%
NZ_JAMDLZ010000027.1:
Lanthipeptides: M5W82_RS15515_lanthipeptide
15
GNKGAYCTLTVEC
27
GN G +CTLT EC
9
GNDGKWCTLTWEC
21
27.9%
NZ_QORY01000016.1:
Lanthipeptides: DT250_RS18255_lanthipeptide
14
LGNKGAYCTLTVECMPSCN
32
LGNKG CT T+EC CN
19
LGNKGRICTYTLECTAGCN
37
27.8%
NZ_CP086141.1:
Lanthipeptides: LL065_RS24800_lanthipeptide
14
LGNKGAYCTLTVECMPSC
31
LGN+G CT +VEC +C
19
LGNQGKICTWSVECQNNC
36
27.5%
NZ_FQZK01000006.1:
Lanthipeptides: BUE45_RS13115_lanthipeptide
14
LGNKGAYCTLTVECMPSC
31
+GN G CTL+VEC SC
23
IGNPGWACTLSVECQGSC
40
27.3%
NZ_AUCI01000015.1:
Lanthipeptides: G475_RS0114640_lanthipeptide
15
GNKGAYCTLTVEC
27
GN G YCT+T EC
11
GNDGDYCTITWEC
23
27.0%
NZ_VTZW01000015.1:
Lanthipeptides: FZ103_RS15850_lanthipeptide
14
LGNKGAYCTLTVECMPSC
31
+GN+G CT+TVEC C
20
VGNEGWACTVTVECQDGC
37
26.8%
NZ_FQZK01000006.1:
Lanthipeptides: BUE45_RS13060_lanthipeptide
10
ISCRL---GNKGAYCTLTVEC
27
I+C L N G +CT+TVEC
14
IACALLSRNNTGRFCTVTVEC
34
25.0%
NZ_CM001792.1:
Lanthipeptides: C794_RS17980_lanthipeptide
15
GNKGAYCTLTVECMPSCN
32
GN+G +CT+T EC +CN
21
GNQGWFCTITKECQVNCN
38
24.3%
NZ_CP115450.1:
Lanthipeptides: O1G21_RS35415_lanthipeptide
14
LGNKGAYCTLTVECMPSCN
32
+GN G CT+T EC +C
18
MGNNGYLCTVTAECQKNCQ
36
21.9%
NZ_CP011152.1:
Lanthipeptides: WR47_RS28820_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSCN
32
IS LGNKG CT+T EC CN
42
ISNTLGNKGHACTITKECQNMCN
64
MIBiG 3.1 matches for BH0454
87.5%
BGC0000517 (BAB04173.1):
Lanthipeptide: haloduracin β or haloduracin α
5
CAWYNISCRLGNKGAYCTLTVECMPSCN
32
CAWYNISCRLGNKGAYCTLTVECMPSCN
1
CAWYNISCRLGNKGAYCTLTVECMPSCN
28
43.8%
BGC0002110 (QKV49893.1):
Lanthipeptide: birimositide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S LGN G +CTLT EC P+CN
6
FSLSNALGNNGGWCTLTKECQPNCN
30
20.5%
BGC0001229 (SBI_06990):
Lanthipeptide: SBI-06990 A1 or SBI-06989 A2
21
CTLTVECMPSCN
32
CTL+ EC P+CN
28
CTLSKECQPNCN
39
with 1 more sequence matches
Lanthipeptide(s) for BH0455
BH0453
Leader:
MVNSKDLRNPEFRKAQGLQFVDEVNEKELSSLAGS
Core:
GDVHAQTTWPCATVGVSVALCPTTKCTSQC
Core with dehydrations:
GDVHAQDhbDhbWPCysADhbVGVDhaVALCysPDhbDhbKCysDhbDhaQCys
antiSMASH-DB 4.0 matches for BH0453
62.5%
NZ_NUML01000015.1:
Lanthipeptides: COD66_RS20140_lanthipeptide
1
GDVHAQTT--WPCATVGVSVALCPTTKCTSQC
30
GDV +TT P VG+SV LCPTTKCTS+C
1
GDVSPETTPATPTIVVGISVGLCPTTKCTSKC
32
60.0%
NZ_JABBGE010000004.1:
Lanthipeptides: HHL19_RS13570_lanthipeptide
7
TTWPCATVG-----VSVALCPTTKCTSQC
30
TTW CA V VS + CPTTKCTSQC
1
TTWSCAVVTAVATLVSASACPTTKCTSQC
29
60.0%
NZ_LMEI01000006.1:
Lanthipeptides: ASC82_RS30550_lanthipeptide
7
TTWPCATVG-----VSVALCPTTKCTSQC
30
TTW CA V VS + CPTTKCTSQC
1
TTWSCAIVTAVATLVSASACPTTKCTSQC
29
with 102 more sequence matches
60.0%
NZ_LT630004.1:
Lanthipeptides: BQ5796_RS18310_lanthipeptide
7
TTWPCA--TVGVSVALCPTTKCTSQC
30
TT PC TV +SV++CPTTKCTSQC
2
TTLPCVGITVTISVSMCPTTKCTSQC
27
59.4%
NZ_CP036019.1:
Lanthipeptides: EXW52_RS27205_lanthipeptide
1
GDVHAQTT--WPCATVGVSVALCPTTKCTSQC
30
GDV +TT P V +SV LCPTTKCTS+C
1
GDVSPETTPATPTIVVAISVGLCPTTKCTSKC
32
58.1%
NC_018499.1:
Lanthipeptides: BCK_RS27845_lanthipeptide
1
GDVHAQTTWPCAT-VGVSVALCPTTKCTSQC
30
GDV+ +TT T V VS+ +CPTTKCTS+C
1
GDVNPETTPATPTIVAVSLGICPTTKCTSKC
31
56.7%
NZ_CP042598.1:
Lanthipeptides: FUT28_RS13815_lanthipeptide
7
TTWPCATVG----VSVALCPTTKCTSQC
30
TTW C V S++LCPTTKCTSQC
1
TTWACVAVSTIVDASISLCPTTKCTSQC
28
56.4%
NZ_CP009288.1:
Lanthipeptides: PDUR_RS29295_lanthipeptide
1
GDVHAQTT------WPCATVGVSVA--LCPTTKCTSQC
30
GDV+ +TT W C T GV+V+ LCPTTKCTSQC
2
GDVNPETTILTTSSWTCITAGVTVSASLCPTTKCTSQC
39
56.2%
NZ_CP013862.1:
Lanthipeptides: AOX59_RS09365_lanthipeptide
1
GDVHAQTTWPCATVGVSVA--LCPTTKCTSQC
30
GDV QTT G++V+ CPTTKCTSQC
1
GDVDPQTTPSSVACGIAVSALFCPTTKCTSQC
32
54.8%
NZ_MLKL01000042.1:
Lanthipeptides: BKK45_RS27405_lanthipeptide
1
GDVHAQTTWPCAT-VGVSVALCPTTKCTSQC
30
GDV+ +TT T V VSV LCPT CT C
1
GDVNPETTPATPTIVAVSVKLCPTGVCTKSC
31
53.3%
NZ_JADPDT010000005.1:
Lanthipeptides: I4V19_RS09875_lanthipeptide
7
TTWPCATVG----VSVALCPTTKCTSQC
30
TTW C V S++LCPTTKCTS+C
1
TTWACVAVSTVVEASISLCPTTKCTSKC
28
53.1%
NZ_CP006058.1:
Lanthipeptides: BAMY6639_RS19790_lanthipeptide
1
GDVHAQTT---WPCATVGVSVALCPTTKCTSQC
30
DV TT PC V V+ A CP+TKCTS C
1
ADVTPHTTPSSLPCG-VFVTAAFCPSTKCTSSC
32
53.1%
NZ_CP036019.1:
Lanthipeptides: EXW52_RS27190_lanthipeptide
1
GDVHAQTT--WPCATVGVSVALCPTTKCTSQC
30
GDV +TT P V +SV LCPT +CTS+C
1
GDVSPETTPATPTIVVAISVGLCPTNRCTSKC
32
52.6%
NC_006322.1:
Lanthipeptides: BLI_RS20290_lanthipeptide
1
GDVHAQTT------WPCATVGVSVA--LCPTTKCTSQC
30
DV+ +TT W C T GV+V+ LCPTTKCTS+C
1
NDVNPETTPATTSSWTCITAGVTVSASLCPTTKCTSRC
38
51.4%
NZ_CM000721.1:
Lanthipeptides: BCERE0010_RS29355_lanthipeptide
1
GDVHAQTTWPC-----ATVGVSVALCPTTKCTSQC
30
GDV+ +TT AT+ V+ +LCPTTKCTS+C
1
GDVNPETTPATPTIIGATIAVTASLCPTTKCTSRC
35
51.3%
NZ_CP009280.1:
Lanthipeptides: P40081_RS37160_lanthipeptide
1
GDVHAQTT------WPC--ATVGVSVALCPTTKCTSQC
30
GDV+ +TT WPC V +S LCPTTKCTS+C
2
GDVNPETTPLTTSSWPCVIGAVDISANLCPTTKCTSKC
39
50.0%
NZ_CP011152.1:
Lanthipeptides: WR47_RS28825_lanthipeptide
1
GDVHAQTTWPCATVGVSVALCPTTKCTSQC
30
GD+ QTT + V VSV PT KC+SQC
1
GDITPQTTDALSAVIVSV--LPTLKCSSQC
28
50.0%
NZ_CP017762.1:
Lanthipeptides: BKP57_RS21840_lanthipeptide
7
TTWPCATVGVSVALCPTTKCTSQC
30
TT PCA V S+ALCPT C+S+C
2
TTVPCA-VAASIALCPTLACSSKC
24
48.6%
NZ_CP015591.1:
Lanthipeptides: A7A70_RS27550_lanthipeptide
1
GDVHAQTTWPC-----ATVGVSVALCPTTKCTSQC
30
GDV+ +TT AT+ +V++CPTTKCTS+C
1
GDVNPETTPATPTIVEATIAATVSICPTTKCTSRC
35
48.5%
NZ_QORY01000016.1:
Lanthipeptides: DT250_RS18265_lanthipeptide
1
GDVHAQTTWPCATVGV-SVALCPTTKCTSQC
30
G+V TTW CA + S A CPTT C+S+C
2
GEVTPYTTWGCAIFTIASAAQCPTTACSSKC
32
47.2%
NZ_CP034118.1:
Lanthipeptides: EG886_RS06300_lanthipeptide
1
GDVHAQTTWPCAT-----VGVSVALCPTTKCTSQC
30
G+V Q+ CA V VS+A CPTT CTS C
1
GEVRPQSGPVCAVTLAVCVPVSLAFCPTTACTSDC
35
43.8%
NC_021362.1:
Lanthipeptides: BALI_RS00915_lanthipeptide
1
GDVHAQTT---WPCATVGVSVALCPTTKCTSQC
30
DV TT PC T+ V+ CP+ CTS C
1
ADVTPHTTPSSLPCGTL-VTAVWCPSNACTSDC
32
43.5%
NZ_AKXV01000031.1:
Lanthipeptides: Y19_RS44045_lanthipeptide
1
GDVHAQTTWPCATVG-----VSVALCPTTKCTSQC
30
DV+ TTW CA V VS + CPTTKCTSQC
12
ADVYGGTTWSCAIVTAVATLVSASACPTTKCTSQC
46
43.3%
NZ_CP036019.1:
Lanthipeptides: EXW52_RS27195_lanthipeptide
1
GDVHAQTT--WPCATVGVSVALCPT
23
GDV +TT P V +SV LCPT
1
GDVSPETTPATPTIVVAISVGLCPT
25
43.3%
NZ_CP040417.1:
Lanthipeptides: FE328_RS05340_lanthipeptide
7
TTWPCATVGVSVALCPTTKCTSQC
30
T+ PC TV VS A+CPT C+++C
3
TSIPC-TVMVSAAVCPTLVCSNKC
25
43.3%
NZ_JANIOB010000033.1:
Lanthipeptides: NQ113_RS28010_lanthipeptide
1
GDVHAQTTWPCATVGVSVALCPTTKCTSQ
29
GDV+ +TT P G + LCPT CT +
1
GDVNPETT-PVINPGFTNRLCPTIPCTLR
28
43.3%
NZ_LR134483.1:
Lanthipeptides: EL241_RS13590_lanthipeptide
13
TVGVSVALCPTTKCTSQC
30
TV +S+ALCPT KCTS+C
6
TVPLSIALCPTAKCTSKC
23
42.9%
NZ_BMMP01000005.1:
Lanthipeptides: IEY56_RS09415_lanthipeptide
1
GDVHAQTTWPCATVGVS-VALCPTTKCTSQC
30
D + T W CATV ++ A+CPTTKCTSQC
12
ADAYGGTAWVCATVTLATAAICPTTKCTSQC
42
42.4%
NZ_NTSF01000026.1:
Lanthipeptides: CN325_RS21840_lanthipeptide
6
QTTWPC---ATVGVSVALCPTTKCTSQC
30
TT PC +T+ +S+A CPT+KCT +C
2
STTVPCGIGSTITISIAYCPTSKCTERC
29
41.9%
NZ_KL997439.1:
Lanthipeptides: IQ62_RS33140_lanthipeptide
1
GDVHAQTT-WPCATVG-VSVALCPTTKCTSQC
30
D H T W ATV VS CPTTKCTS C
12
ADTHGGTGPWCIATVTLVSAVACPTTKCTSSC
43
40.0%
NZ_CP040938.1:
Lanthipeptides: B5772_RS02455_lanthipeptide
7
TTWPCATVGVSVALCPTTKCTSQC
30
T+ PCA V S A+CPT C+++C
3
TSIPCA-VMASTAICPTLVCSNKC
25
40.0%
NZ_JFCR01000001.1:
Lanthipeptides: JQ44_RS10210_lanthipeptide
17
SVALCPTTKCTSQC
30
SVALCPTTKC+S C
13
SVALCPTTKCSSAC
26
39.5%
NZ_GG657757.1:
Lanthipeptides: SSQG_RS41860_lanthipeptide
1
GDVHAQTT-WPCATVG-VSVALCPTTKCTSQC
30
D H T W ATV V+ +CPTTKCTS+C
12
ADNHGGTGPWCIATVTLVTATVCPTTKCTSKC
43
39.4%
NZ_JACSJU010000005.1:
Lanthipeptides: KNO78_RS14610_lanthipeptide
1
GDVHAQTTWPCATVG---VSVALCPTTKC
26
GDV +TT CA G SVA+ KC
1
GDVQPETTTLCAFTGGITFSVAMSKLFKC
29
38.6%
NZ_BNCA01000011.1:
Lanthipeptides: IE314_RS15870_lanthipeptide
4
HAQTTWP---CATVGVSVALCPTTKCTSQC
30
H TT P +V VS A CPTTKCTS+C
15
HGGTTSPVCIATSVAVSTAFCPTTKCTSKC
44
38.2%
NZ_CP036019.1:
Lanthipeptides: EXW52_RS27165_lanthipeptide
1
GDVHAQTTWPCAT---VGVSVALCPTTKCTSQC
30
GDV+ +T AT ++ LCP+ CTS+C
1
GDVNPETIPATATPILANLTKELCPSIPCTSRC
33
38.2%
NZ_JACSPO010000013.1:
Lanthipeptides: H9624_RS14885_lanthipeptide
7
TTWPCATVGVSVAL-------CPTTKCTSQC
30
TT PCA G +A+ CPT CT++C
4
TTVPCAIGGGVIAISAALPDFCPTGACTTRC
34
37.5%
NZ_CP011152.1:
Lanthipeptides: WR47_RS28835_lanthipeptide
1
GDVHAQTTWPCATV-------GVSVALCPTTKCTSQC
30
GDV Q T P T+ V A+ PT KC+S+C
1
GDVTPQAT-PTVTILATAAGGAVISAVLPTLKCSSKC
36
37.2%
NZ_CP107567.1:
Lanthipeptides: OGH68_RS19755_lanthipeptide
9
WPCATVG-VSVALCPTTKCTSQC
30
W ATV VS A+CPTTKCTS C
21
WCIATVTLVSAAMCPTTKCTSAC
43
37.1%
NZ_JALGRP010000007.1:
Lanthipeptides: MT347_RS12965_lanthipeptide
7
TTWPCATVGVSVA-------LCPTTKCTSQC
30
TT PCA G+++A CPT CT++C
2
TTAPCAVAGLTIAATAALPGFCPTGACTTRC
32
36.8%
NZ_BMFU01000012.1:
Lanthipeptides: IEW26_RS25390_lanthipeptide
2
DVHAQTTWPCA--------TVGVSVALCPTTKCTSQC
30
+V A ++WPCA T+ S CP+T C+S+C
2
EVQAASSWPCAIVPPVVIWTITDSANSCPSTACSSRC
38
36.7%
NZ_AP026721.1:
Lanthipeptides: PO855_RS02215_lanthipeptide
1
GDVHAQTTWPCATVGVSVALCPTTK
25
GDV A+TT C T+G+ V + K
1
GDVQAETTPACFTIGLGVGALFSAK
25
36.7%
NZ_BJTV01000004.1:
Lanthipeptides: TNCT1_RS35800_lanthipeptide
18
VALCPTTKCTSQC
30
VA CPTTKCTS C
1
VAFCPTTKCTSAC
13
36.7%
NZ_CP016076.1:
Lanthipeptides: UA74_RS09535_lanthipeptide
7
TTWPCATVGVSVALCPTTK
25
TTWPC + VS+A C TK
1
TTWPCFGITVSIAACQGTK
19
36.7%
NZ_CP039292.1:
Lanthipeptides: E4J16_RS14990_lanthipeptide
7
TTWPCATVGVSVALCPTTKCTSQC
30
++WPC +G++ +CPT CTS+C
5
SSWPCG-IGITTTICPTAVCTSKC
27
36.7%
NZ_CP050134.2:
Lanthipeptides: HBA49_RS00775_lanthipeptide
8
TWPCATVGVSVALCPTTKCTSQC
30
T P + +S+ALCPTT+C+ +C
1
THPSTLIPISIALCPTTRCSRRC
23
36.7%
NZ_CP084530.1:
Lanthipeptides: LDO05_RS02090_lanthipeptide
7
TTWPCATVGVSVALCPTTKCTSQC
30
++W C S A CP+T CTS+C
7
SSWICGVA--SAAFCPSTACTSKC
28
36.7%
NZ_JACDUU010000003.1:
Lanthipeptides: HNQ85_RS08030_lanthipeptide
1
GDVHAQTTWPCA-TVGVSVAL
20
GDV +TT PCA T+GV++ +
1
GDVQPETTTPCAYTIGVTIGI
21
36.7%
NZ_JH791802.1:
Lanthipeptides: IKS_RS03655_lanthipeptide
1
GDVHAQTTWPCATVGVSVA
19
GDV A+TT C TVG+ V
1
GDVQAETTPVCFTVGLGVG
19
35.5%
NZ_LT985747.1:
Lanthipeptides: C8268_RS00150_lanthipeptide
7
TTWPCATVGVSVALCPTTKCTSQC
30
++W C V + ALCP+T CT C
10
SSWICGFV--TAALCPSTACTGDC
31
35.3%
NZ_NUML01000015.1:
Lanthipeptides: COD66_RS20280_lanthipeptide
1
GDVHAQTTWPCAT---VGVSVALCPTTKCTSQC
30
GD++ +T T V ++ LCP+ CTS+C
1
GDMNPETIPATPTPILVNLTKELCPSIPCTSRC
33
34.9%
NZ_JAASAG010000001.1:
Lanthipeptides: HCC61_RS01465_lanthipeptide
9
WPCATVGVS-VALCPTTKCTSQC
30
W ATV ++ A+CPTTKCTSQC
21
WCVATVTLATAAICPTTKCTSQC
43
34.9%
NZ_QLLX01000002.1:
Lanthipeptides: K378_RS30040_lanthipeptide
9
WPCATVGVS-VALCPTTKCTSQC
30
W ATV ++ A+CPTTKCTSQC
21
WCIATVTLATAAICPTTKCTSQC
43
34.2%
NZ_JACHKG010000014.1:
Lanthipeptides: HNR77_RS17300_lanthipeptide
2
DVHAQTTWPCA--------TVGVSVALCPTTKCTSQC
30
+V ++WPCA T+ S CP+T C+S+C
2
EVQVASSWPCAIVPPVVIWTITDSANSCPSTACSSRC
38
34.2%
NZ_JAHXMW010000012.1:
Lanthipeptides: KZX51_RS23840_lanthipeptide
2
DVHAQTTWPCA--------TVGVSVALCPTTKCTSQC
30
+V ++WPCA T+ S CP+T C+S+C
2
EVQVASSWPCAIVPPVLIWTITDSANSCPSTACSSRC
38
33.3%
NZ_BOSN01000007.1:
Lanthipeptides: KJS43_RS18000_lanthipeptide
10
PCATVGVSVALCPTTKCTS
28
P + VS+A+CPTTKC S
8
PATIIPVSLAICPTTKCAS
26
33.3%
NZ_CP011974.1:
Lanthipeptides: BEH_RS02100_lanthipeptide
1
GDVHAQTTWPCATVGVSVA
19
GDV A+TT C T+G+ V
1
GDVQAETTPVCFTIGLGVG
19
33.3%
NZ_CP025249.1:
Lanthipeptides: CWT12_RS00390_lanthipeptide
7
TTWPCATVGVSVALCPTTKCTSQC
30
++WPC +G++ +CPT C+S+C
5
SSWPCG-IGITTTVCPTAACSSKC
27
33.3%
NZ_JH791802.1:
Lanthipeptides: IKS_RS03660_lanthipeptide
1
GDVHAQTTWPCATVGVSVA
19
GDV A+TT C TVG+ +
1
GDVQAETTPVCFTVGLGIG
19
33.3%
NZ_KE384107.1:
Lanthipeptides: G586_RS26715_lanthipeptide
14
VGVSVALCPTTKCTSQC
30
+ S A CPT KCTS+C
14
IAASTAFCPTIKCTSKC
30
33.3%
NZ_MJEJ02000054.1:
Lanthipeptides: BH683_RS28810_lanthipeptide
16
VSVALCPTTKCT
27
+SVALCPT KCT
12
LSVALCPTFKCT
23
33.3%
NZ_MLKL01000042.1:
Lanthipeptides: BKK45_RS27415_lanthipeptide
1
GDVHAQTTWPCATVGVSVA-----LCPTTKCTSQ
29
GDV+ +T TV + + LCPT CT Q
1
GDVNPETMPGPVTVTIVIPVFTNKLCPTVPCTRQ
34
33.3%
NZ_NTSR01000029.1:
Lanthipeptides: CN358_RS25165_lanthipeptide
2
DVHAQTTWPCATVGVSVAL-----------CPTTKCTSQC
30
+V+ +TT PCA G +V + CPT+ C+S+C
2
EVNPRTTVPCAVGGATVGITIYTFDRSHQSCPTSACSSRC
41
32.4%
NZ_CP084663.1:
Lanthipeptides: LA357_RS19865_lanthipeptide
2
DVHAQTTWPCATVGVSV
18
DV AQTT A+V VSV
1
DVEAQTTPTIASVLVSV
17
32.4%
NZ_WIXN01000006.1:
Lanthipeptides: GHD25_RS06900_lanthipeptide
8
TWPCATVGVSVALCPTTKCTS
28
T P + VS+A+CPTT C S
7
THPTTIIPVSLAVCPTTTCRS
27
30.3%
NZ_CP070496.1:
Lanthipeptides: JQS30_RS16095_lanthipeptide
7
TTWPCATVGVSVALCPTTK
25
TTW CATV ++V +C T
1
TTWGCATVTLTVTVCSPTN
19
30.2%
NZ_BJTV01000004.1:
Lanthipeptides: TNCT1_RS35805_lanthipeptide
13
TVGVSVALCPTTKCTSQC
30
TV SVA CPT KCTS C
26
TVAASVAFCPTIKCTSAC
43
30.0%
NZ_CP040417.1:
Lanthipeptides: FE328_RS09035_lanthipeptide
14
VGVSVALCPTTKCTS
28
V +S+A+CP+TKC S
7
VPISLAICPSTKCAS
21
30.0%
NZ_CP063142.1:
Lanthipeptides: HPB58_RS12640_lanthipeptide
1
GDVHAQTTWPCATV
14
DV QTTWPC V
1
SDVSPQTTWPCVVV
14
30.0%
NZ_FOBE01000018.1:
Lanthipeptides: BMW61_RS21935_lanthipeptide
13
TVGVSVALCPTTKCTSQC
30
T+ S A CP+ KC+S+C
13
TIAASTAFCPSIKCSSKC
30
30.0%
NZ_JAOVZP010000016.1:
Lanthipeptides: OF830_RS26680_lanthipeptide
1
GDVHAQTTWPCATVGVS
17
GDV +TT C T+GV
1
GDVSPETTPLCITIGVG
17
30.0%
NZ_KE384533.1:
Lanthipeptides: K329_RS31315_lanthipeptide
16
VSVALCPTTKCTSQC
30
VS CPTT CT +C
13
VSTNTCPTTSCTDEC
27
30.0%
NZ_KZ845663.1:
Lanthipeptides: DL897_RS01070_lanthipeptide
1
GDVHAQTTWPCATVGVSVALC
21
D QTT PC + SV +C
1
SDTQPQTTVPCLAITFSVFMC
21
29.4%
NZ_CP101913.1:
Lanthipeptides: NP440_RS09140_lanthipeptide
10
PCATVGVSVALCPTTKCTS
28
P T+ +S A+CPTT+C S
8
PTVTIPISAAICPTTQCAS
26
29.4%
NZ_KQ040792.1:
Lanthipeptides: WH45_RS23705_lanthipeptide
10
PCATVGVSVALCPTTKCTS
28
P + VS+A+CPTT+C S
9
PATIIPVSLAICPTTRCAS
27
28.9%
NZ_CP017953.1:
Lanthipeptides: BAMY_RS16390_lanthipeptide
13
TVGVSVALCPTTKCTSQC
30
TV +S A CPT+ CT QC
19
TVTLSAASCPTSACTKQC
36
28.9%
NZ_JALIRS010000003.1:
Lanthipeptides: MOK21_RS07280_lanthipeptide
1
GDVHAQTTWPCA------TVGVSVALCPTTKCTSQC
30
G+V+ +++W C T+ S+ CP+T C+++C
1
GEVNPRSSWGCVIDVTIWTITDSMNSCPSTACSTRC
36
28.9%
NZ_JALIRS010000003.1:
Lanthipeptides: MOK21_RS07275_lanthipeptide
1
GDVHAQTTWPCA------TVGVSVALCPTTKCTSQC
30
G+V+ +++W C T+ S+ CP+T C+++C
1
GEVNPRSSWGCVVQVTIYTISDSMNSCPSTACSTRC
36
28.6%
NZ_CP085411.1:
Lanthipeptides: LIT28_RS29915_lanthipeptide
15
GVSVALCPTTKCTSQC
30
G ++++CPTTKCTS+C
20
GATISVCPTTKCTSRC
35
28.6%
NZ_JAMDLZ010000027.1:
Lanthipeptides: M5W82_RS15520_lanthipeptide
13
TVGVSVALCPTTKCTS
28
T+ +S+A CPTTKC S
13
TIPISLAGCPTTKCAS
28
28.6%
NZ_QNUC01000031.1:
Lanthipeptides: DN396_RS23045_lanthipeptide
15
GVSVALCPTTKCTSQC
30
G ++++CPTTKCTS+C
20
GATISICPTTKCTSRC
35
28.2%
NZ_WHOM01000078.1:
Lanthipeptides: GCN81_RS29290_lanthipeptide
14
VGVSVAL---CPTTKCTSQC
30
VG S AL CPT+ CT +C
20
VGASAALQGGCPTSGCTKRC
39
28.1%
NZ_CP063142.1:
Lanthipeptides: HPB58_RS21455_lanthipeptide
13
TVGVSVALCPTTKCTS
28
T+ +S+A CPTT+C S
10
TIPISLAACPTTQCAS
25
28.1%
NZ_JANIOB010000033.1:
Lanthipeptides: NQ113_RS28015_lanthipeptide
19
ALCPTTKCTSQC
30
ALCPT +CTS+C
21
ALCPTPRCTSRC
32
27.9%
NZ_BNBV01000031.1:
Lanthipeptides: IE286_RS22990_lanthipeptide
13
TVGVSVALCPTTKCTSQC
30
TV S A CPTTKCT+ C
26
TVAASAAFCPTTKCTNDC
43
27.8%
NZ_CP047645.1:
Lanthipeptides: GSN02_RS17435_lanthipeptide
13
TVGVSVALCPTTKCTSQC
30
TV +S A CPT+ CT+ C
17
TVTLSAASCPTSACTNLC
34
27.3%
NZ_CP102975.1:
Lanthipeptides: NW953_RS00175_lanthipeptide
14
VGVSVALCPTTKCTSQC
30
V S A CPT C+S+C
12
VAASTAQCPTLACSSRC
28
27.3%
NZ_DS999644.1:
Lanthipeptides: SSGG_RS13165_lanthipeptide
7
TTWPCATVGVSVALC
21
TTW CATV ++V +C
1
TTWACATVTLTVTVC
15
27.0%
NZ_CM001792.1:
Lanthipeptides: C794_RS17975_lanthipeptide
14
VGVSVALCPTTKCTSQC
30
V +S+A CPT+ CTS C
18
VAISLAFCPTSACTSDC
34
26.7%
NZ_BQME02000001.1:
Lanthipeptides: MFF31_RS04090_lanthipeptide
14
VGVSVALCPTTKCTS
28
+ +S+A CPTT+C S
9
IPISLAACPTTRCAS
23
26.7%
NZ_FQZK01000006.1:
Lanthipeptides: BUE45_RS13105_lanthipeptide
21
CPTTKCTSQC
30
CPTT CTS+C
19
CPTTVCTSRC
28
26.7%
NZ_JAHHYI010000012.1:
Lanthipeptides: KM925_RS25405_lanthipeptide
1
GDVHAQTTWPCATVGVSVAL
20
GDV +TT C G++V +
1
GDVQPETTPACVGAGITVGI
20
26.7%
NZ_NTSF01000026.1:
Lanthipeptides: CN325_RS31015_lanthipeptide
19
ALCPTTKCTSQC
30
A CPT+KCT++C
1
AFCPTSKCTTRC
12
26.5%
NZ_KV917378.1:
Lanthipeptides: BK581_RS20095_lanthipeptide
13
TVGVSVALCPTTKCTS
28
T+ +S A CPTT+C S
12
TIPISAAACPTTQCAS
27
25.9%
NC_016582.1:
Lanthipeptides: SBI_RS34370_lanthipeptide
14
VGVSVALCPTTKCTSQC
30
VGVS A CPTTKCTS+C
38
VGVSAAFCPTTKCTSRC
54
25.0%
NC_023073.1:
Lanthipeptides: U722_RS19995_lanthipeptide
17
SVALCPTTKCTS
28
S+A CPTTKC S
18
SLAGCPTTKCAS
29
24.2%
NZ_BMTW01000001.1:
Lanthipeptides: IE134_RS03420_lanthipeptide
7
TTWPCATVGVSVALC
21
TTW CAT+ ++V +C
1
TTWACATITLTVTVC
15
23.8%
NZ_BMRY01000003.1:
Lanthipeptides: IE140_RS12360_lanthipeptide
14
VGVSVAL---CPTTKCTSQC
30
VG S A+ CPT+ CT +C
23
VGASAAMQGGCPTSGCTKRC
42
23.3%
NZ_BIFH01000022.1:
Lanthipeptides: EMA17_RS52585_lanthipeptide
16
VSVALCPTTKCTSQC
30
++ +CPTT C+S+C
14
ITATMCPTTACSSKC
28
22.6%
NZ_NVJC01000007.1:
Lanthipeptides: COM38_RS07270_lanthipeptide
15
GVSVALCPTTKC
26
G ++++CPTTKC
20
GATISVCPTTKC
31
22.2%
NZ_CP047419.1:
Lanthipeptides: GTU71_RS12785_lanthipeptide
17
SVALCPTTKCTSQC
30
S LCPT CT +C
23
SSGLCPTFSCTGEC
36
20.0%
NZ_CP036019.1:
Lanthipeptides: EXW52_RS27200_lanthipeptide
8
TWPCATVGVSVALCPTTK
25
T+ C G SV LCPT +
24
TYNCG--GKSVGLCPTNR
39
19.6%
NZ_JAJAGO010000028.1:
Lanthipeptides: LHJ74_RS33595_lanthipeptide
7
TTWPCATVGVSVALCPTTKCTSQC
30
++W C T ++++CPT+ C+S+C
24
SSWTCITAA-TISICPTSACSSKC
46
18.6%
NZ_CP016795.1:
Lanthipeptides: BC342_RS37680_lanthipeptide
20
LCPTTKCTSQC
30
CPTTKCT +C
33
FCPTTKCTKEC
43
18.2%
NZ_FPCC01000026.1:
Lanthipeptides: BM377_RS12925_lanthipeptide
1
GDVHAQTTWPCATV
14
GDV A+TT P + V
17
GDVEAETTVPLSVV
30
MIBiG 3.1 matches for BH0453
37.8%
BGC0001229 (SBI_06989):
Lanthipeptide: SBI-06990 A1 or SBI-06989 A2
14
VGVSVALCPTTKCTSQC
30
VGVS A CPTTKCTS+C
21
VGVSAAFCPTTKCTSRC
37
BH0454
Leader:
MTNLLKEWKMPLERTHNNSNPAGDIFQELEDQDILAG
Core:
VNGACAWYNISCRLGNKGAYCTLTVECMPSCN
Core with dehydrations:
VNGACysAWYNIDhaCysRLGNKGAYCysDhbLDhbVECysMPDhaCysN
antiSMASH-DB 4.0 matches for BH0454
100.0%
NC_002570.2:
Lanthipeptides: AYT26_RS02480_lanthipeptide
1
VNGACAWYNISCRLGNKGAYCTLTVECMPSCN
32
VNGACAWYNISCRLGNKGAYCTLTVECMPSCN
1
VNGACAWYNISCRLGNKGAYCTLTVECMPSCN
32
71.9%
NZ_CP006058.1:
Lanthipeptides: BAMY6639_RS13800_lanthipeptide
5
CAWYNISCRLGNKGAYCTLTVECMPSCN
32
CAWY+ISC+LGNKGA+CTLTVEC SCN
1
CAWYDISCKLGNKGAWCTLTVECQSSCN
28
68.8%
NZ_CP063276.1:
Lanthipeptides: IM743_RS02795_lanthipeptide
5
CAWYNISCRLGNKGAYCTLTVECMPSCN
32
CAWY++SCRLGNKGA+CTLTVEC +CN
1
CAWYDVSCRLGNKGAWCTLTVECQNNCN
28
with 101 more sequence matches
62.5%
NC_021362.1:
Lanthipeptides: BALI_RS00925_lanthipeptide
5
CAWYNISCRLGNKGAYCTLTVECMPSCN
32
C WYNISC+LGNKG +CTLT EC SC
1
CEWYNISCQLGNKGQWCTLTKECQRSCK
28
62.5%
NZ_CP034118.1:
Lanthipeptides: EG886_RS06310_lanthipeptide
5
CAWYNISCRLGNKGAYCTLTVECMPSCN
32
C W+NISC LGN G +CTLT EC PSCN
1
CDWWNISCHLGNTGQFCTLTKECQPSCN
28
59.4%
NZ_CP034118.1:
Lanthipeptides: EG886_RS06305_lanthipeptide
5
CAWYNISCRLGNKGAYCTLTVECMPSCN
32
C W+NISC LGN G +CTLT EC P+CN
1
CDWWNISCHLGNTGRFCTLTKECQPNCN
28
56.2%
NC_018499.1:
Lanthipeptides: BCK_RS27860_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSCN
32
+S LGNKG YCTLT ECMPSCN
10
LSSWLGNKGGYCTLTKECMPSCN
32
56.2%
NZ_NTSF01000026.1:
Lanthipeptides: CN325_RS21845_lanthipeptide
5
CAWYNISCRLGNKGAYCTLTVECMPSCN
32
C+W+N+SC LGN G YCT + ECMP+CN
2
CSWWNVSCHLGNDGKYCTASKECMPTCN
29
53.1%
NZ_CP015591.1:
Lanthipeptides: A7A70_RS27565_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSCN
32
+S LGN G YCTLT ECMPSCN
10
LSSWLGNNGGYCTLTKECMPSCN
32
53.1%
NZ_CP036019.1:
Lanthipeptides: EXW52_RS27215_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSCN
32
+S LGNKG YCTLT ECM SCN
10
LSSWLGNKGGYCTLTKECMSSCN
32
53.1%
NZ_LT630004.1:
Lanthipeptides: BQ5796_RS17475_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSCN
32
+S LGN G +CTLTVECMPSCN
2
LSSLLGNDGKFCTLTVECMPSCN
24
53.1%
NZ_NTSF01000026.1:
Lanthipeptides: CN325_RS21835_lanthipeptide
5
CAWYNISCRLGNKGAYCTLTVECMPSC
31
C ++NISC LGN G+ CTLT EC P+C
2
CNFWNISCHLGNDGSVCTLTKECRPAC
28
50.0%
NZ_CP017762.1:
Lanthipeptides: BKP57_RS02100_lanthipeptide
5
CAWYNISCRLGNKGAYCTLTVECMPSCN
32
C WYN+SC LGN G CT + EC CN
2
CPWYNLSCHLGNDGKICTFSHECTGGCN
29
50.0%
NZ_CP036016.1:
Lanthipeptides: allorf_075467_075682_lanthipeptide
5
CAWYNISCRLGNKGAYCTLTVECMPSC
31
C W+++SC LGN G+ CTL+VEC P+C
2
CTWWDLSCHLGNDGSTCTLSVECRPAC
28
50.0%
NZ_CP102975.1:
Lanthipeptides: NW953_RS00170_lanthipeptide
3
GACAWYNISCRLGNKGAYCTLTVECMPSCN
32
G C+W+N+SC LGN G CT++ EC CN
1
GKCSWWNLSCHLGNNGKLCTVSHECAAGCN
30
50.0%
NZ_FOBE01000018.1:
Lanthipeptides: BMW61_RS13085_lanthipeptide
7
WYN-ISCRLGNKGAYCTLTVECMPSCN
32
WY+ +S LGN+G+YCTLT EC CN
2
WYSEMSAALGNRGSYCTLTKECQACCN
28
50.0%
NZ_LR134483.1:
Lanthipeptides: EL241_RS01720_lanthipeptide
7
WYNISCRLGNKGAYCTLTVECMPSCN
32
W+N+S LGNKG CTLT EC CN
1
WWNVSKNLGNKGRICTLTKECQSMCN
26
46.9%
NC_006322.1:
Lanthipeptides: BLI_RS20295_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSCN
32
+S LGN G CT+T ECMPSCN
10
LSKPLGNNGYLCTVTKECMPSCN
32
46.9%
NZ_BMMP01000005.1:
Lanthipeptides: IEY56_RS28370_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S LGN G +CTLTVEC P+CN
6
FSLSDVLGNTGGWCTLTVECQPNCN
30
46.9%
NZ_CP050134.2:
Lanthipeptides: HBA49_RS00770_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSCN
32
+S LGN G +CT+T ECMPSCN
1
LSRLLGNNGRWCTITKECMPSCN
23
46.9%
NZ_KE384107.1:
Lanthipeptides: G586_RS23925_lanthipeptide
6
AWY-NISCRLGNKGAYCTLTVECMPSCN
32
WY ++S LGN+G+YCT+T EC CN
1
GWYADLSASLGNRGSYCTITKECQACCN
28
46.9%
NZ_LT985747.1:
Lanthipeptides: C8268_RS00165_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+ +S LGNKG +CTLT EC SCN
6
FTLSDYLGNKGGWCTLTKECQRSCN
30
44.4%
NZ_CP009288.1:
Lanthipeptides: PDUR_RS25150_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSCN
32
IS LGN G CT T ECMPSCN
14
ISMTLGNNGWVCTATKECMPSCN
36
44.1%
NZ_CP042598.1:
Lanthipeptides: FUT28_RS13825_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S LGN G +CT T ECMPSCN
10
FSLSDYLGNTGGWCTATKECMPSCN
34
44.1%
NZ_JADPDT010000005.1:
Lanthipeptides: I4V19_RS09885_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S LGN G +CT T ECMPSCN
10
FSLSDFLGNTGGWCTATKECMPSCN
34
43.8%
NZ_AKXV01000031.1:
Lanthipeptides: Y19_RS0109895_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S LGN+G +CTLT EC P+CN
6
FSLSDFLGNQGGWCTLTKECQPNCN
30
43.8%
NZ_BNBV01000031.1:
Lanthipeptides: IE286_RS22995_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S LGN G +CTLT EC P+CN
6
FSLSDALGNSGGWCTLTKECQPNCN
30
43.8%
NZ_CKMQ01000043.1:
Lanthipeptides: AE832_RS11585_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSC
31
IS LGNKGA CT T+EC +C
8
ISEALGNKGAVCTGTIECQNNC
29
43.8%
NZ_CP043405.1:
Lanthipeptides: FY406_RS04355_lanthipeptide
11
SCRLGNKGAYCTLTVECMPSCN
32
S LGNKG CT+TVECM +C
11
SIVLGNKGYICTVTVECMRNCQ
32
43.8%
NZ_CP047419.1:
Lanthipeptides: GTU71_RS12805_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+ +S LGN+G +CTLTVEC P+C
6
FTLSNVLGNQGGWCTLTVECQPNC
29
43.8%
NZ_CP084530.1:
Lanthipeptides: LDO05_RS02075_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+ +S LGN G +CTLT EC SCN
6
FTLSNYLGNNGGWCTLTKECQRSCN
30
43.8%
NZ_CP107567.1:
Lanthipeptides: OGH68_RS19760_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S LGN+G +CTLT EC P+CN
6
FSLSDWLGNQGGWCTLTKECQPNCN
30
43.8%
NZ_JAASAG010000001.1:
Lanthipeptides: HCC61_RS30395_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S L N G +CTLTVEC P+CN
6
FSLSDALTNTGGWCTLTVECQPNCN
30
43.8%
NZ_KV795763.1:
Lanthipeptides: allorf_248182_248337_lanthipeptide
6
AWYNISCRLGNKGAYCTLTVECMPSCN
32
WY S +GN+G CT+TVECM C
5
GWY--SKVIGNRGRVCTVTVECMSVCQ
29
43.8%
NZ_LR134483.1:
Lanthipeptides: EL241_RS01725_lanthipeptide
6
AWYNISCRLGNKGAYCTLTVECMPSCN
32
W ++S LGNKG CTLT EC C
2
GWKDLSKSLGNKGYVCTLTKECQKLCR
28
43.8%
NZ_QLLX01000002.1:
Lanthipeptides: K378_RS05175_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S L N+G +CTLTVEC P+CN
6
FSLSDALTNQGGWCTLTVECQPNCN
30
42.4%
NC_018089.1:
Lanthipeptides: SMUGS5_RS08725_lanthipeptide
11
SCRLGNKGAYCTLTVECMPSCN
32
S LGNKG CT+TVECM +C+
11
SIVLGNKGYICTVTVECMRNCS
32
42.4%
NZ_KL997439.1:
Lanthipeptides: IQ62_RS47105_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+ +S +LG+KG CT T EC PSCN
9
FTLSAQLGDKGDCCTATKECQPSCN
33
42.1%
NZ_CP013862.1:
Lanthipeptides: AOX59_RS09360_lanthipeptide
5
CAWYNISCRLGNKGAYCTLTVECMPSCN
32
C W IS +GN G CT TVEC P+CN
13
CHW--ISPAMGNDGHLCTATVECQPNCN
38
41.7%
NZ_CP009280.1:
Lanthipeptides: P40081_RS01820_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSCN
32
IS LGN G CT + ECMPSCN
14
ISRGLGNDGWVCTWSKECMPSCN
36
40.6%
NZ_BJTV01000004.1:
Lanthipeptides: TNCT1_RS10200_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S LGN G +CTLT EC +CN
6
FSLSDALGNHGGWCTLTKECQANCN
30
40.6%
NZ_BLIS01000009.1:
Lanthipeptides: GVO03_RS04820_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+++S GNKG +CTLT ECM C
6
FSLSDYWGNKGNWCTLTHECMNWC
29
40.6%
NZ_BNCA01000011.1:
Lanthipeptides: IE314_RS15865_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S +GN G +CTLT EC P+CN
6
FSLSDAVGNHGGWCTLTKECQPNCN
30
40.6%
NZ_CP016795.1:
Lanthipeptides: BC342_RS18360_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S LGN G +CTLT EC P+C+
6
FSLSDALGNHGGWCTLTKECQPNCS
30
40.6%
NZ_CP025249.1:
Lanthipeptides: CWT12_RS00385_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSCN
32
+S +LGN G CTLT EC CN
5
LSRKLGNTGYVCTLTKECQRMCN
27
40.6%
NZ_CP043317.1:
Lanthipeptides: FYC74_RS17680_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S LGN G +CTLT EC P+C+
6
FSLSDSLGNHGGWCTLTKECQPNCS
30
40.0%
NZ_BIFH01000022.1:
Lanthipeptides: EMA17_RS23445_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSCN
32
S LGN G +CTLT EC SCN
13
FSNDLGNHGNWCTLTKECQRSCN
35
39.4%
NZ_GG657757.1:
Lanthipeptides: SSQG_RS20730_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S GN G CTLT EC SCN
9
FSLSGIFGNDGDCCTLTKECQASCN
33
37.5%
NZ_AP026714.1:
Lanthipeptides: PO853_RS06515_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+++S GNKG +CT T ECM C
6
FSLSDYWGNKGNWCTATHECMGWC
29
37.5%
NZ_CP027862.1:
Lanthipeptides: allorf_0097945_0098112_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S GN+G +CTLT ECM C
6
FSLSDYWGNRGYWCTLTHECMSWCK
30
37.5%
NZ_CP061868.1:
Lanthipeptides: IE339_RS06330_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+++S GNKG +CT T ECM C
6
FSLSDYWGNKGGWCTATHECMSWC
29
37.5%
NZ_GG657754.1:
Lanthipeptides: SSOG_RS49055_lanthipeptide
6
AWYNISCRLGNKGAYCTLTVECMPSC
31
A Y +S +GN G +CT T+EC +C
5
AEYVVSFVMGNLGNFCTATLECQKNC
30
37.5%
NZ_JAJAGO010000028.1:
Lanthipeptides: LHJ74_RS33590_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S GN G +CTLT EC +CN
6
FSLSDAAGNDGWWCTLTKECQRTCN
30
35.6%
NZ_JACEIQ010000001.1:
Lanthipeptides: H1191_RS00080_lanthipeptide
15
GNKGAYCTLTVECMPSCN
32
GN G YCTLTVECMPSCN
28
GNDGWYCTLTVECMPSCN
45
35.3%
NZ_BQXZ01000001.1:
Lanthipeptides: OCU69_RS05000_lanthipeptide
2
NGACAWYNISCRLGNKGAYCTLTVECMPSCN
32
+G +S +GNKG+ CT T+EC +C+
3
SGGTISITLSVYMGNKGSVCTWTIECQSNCS
33
35.1%
NZ_QKTG01000020.1:
Lanthipeptides: DEI99_RS16920_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
Y +S LGN G +CT TVEC +C
13
YGVSWALGNDGNFCTATVECQSNC
36
34.4%
NZ_CACZYW010000004.1:
Lanthipeptides: HUF10_RS02825_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+++S GN G +CTL+ ECM C
6
FSLSDYWGNNGNWCTLSHECMAWC
29
34.4%
NZ_CP016767.1:
Lanthipeptides: BCV50_RS13410_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+++S GNKG +CT++ ECM C
6
FSLSDYWGNKGGWCTVSKECMAWC
29
34.4%
NZ_CP030280.1:
Lanthipeptides: DQQ01_RS07655_lanthipeptide
15
GNKGAYCTLTVECMPSCN
32
GN G C++TVECM CN
7
GNDGYLCSVTVECMIICN
24
34.4%
NZ_CP030280.1:
Lanthipeptides: DQQ01_RS07650_lanthipeptide
15
GNKGAYCTLTVECMPSCN
32
GN G C++TVECM CN
7
GNDGYLCSVTVECMVICN
24
34.4%
NZ_CP034414.1:
Lanthipeptides: EI692_RS18440_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+++S GNKG +CT++ ECM C
6
FSLSDYWGNKGGWCTISHECMSWC
29
34.4%
NZ_CP051884.1:
Lanthipeptides: HGK68_RS15125_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+++S GN G CT+T ECM C
6
FSLSDYWGNNGWLCTITHECMSWC
29
34.4%
NZ_KE384533.1:
Lanthipeptides: K329_RS0118200_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+++S GN G +CTL+ ECM C
6
FSLSDAYGNTGGWCTLSQECMSWC
29
34.4%
NZ_MJEJ02000054.1:
Lanthipeptides: BH683_RS28205_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+ +S LGN G +CTLT E +C
6
FTLSDFLGNDGGWCTLTKESQNNC
29
34.4%
NZ_PCGR01000003.1:
Lanthipeptides: CQS04_RS09620_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+++S GN G +CT T ECM C
6
FSLSDYWGNNGNWCTATHECMSWC
29
34.4%
NZ_QGEE01000020.1:
Lanthipeptides: DKP74_RS06160_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+++S GN+G +CTL+ ECM C
6
FSLSDYWGNRGNWCTLSHECMAWC
29
34.2%
NZ_CM000756.1:
Lanthipeptides: BTHUR0011_RS34475_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSC
31
IS GNKG CT TVEC+ +C
15
ISETFGNKGKVCTYTVECVNNC
36
33.3%
NZ_JALGRP010000007.1:
Lanthipeptides: MT347_RS12955_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
Y +S GN G CT TVEC +CN
15
YGVSWVAGNNGQVCTATVECQNNCN
39
32.5%
NZ_JALIRS010000003.1:
Lanthipeptides: MOK21_RS07255_lanthipeptide
14
LGNKGAYCTLTVECMPSCN
32
LGN G CTLTVEC CN
22
LGNPGHVCTLTVECQKKCN
40
32.4%
NZ_BCEY01000006.1:
Lanthipeptides: GOZ53_RS01290_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSCN
32
IS LGN G CT T EC +C
15
ISFALGNDGWICTWTAECQATCK
37
32.4%
NZ_CP017953.1:
Lanthipeptides: BAMY_RS16400_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSC
31
+S LGNKG CT T EC +C
16
VSEVLGNKGKVCTGTKECQGTC
37
32.4%
NZ_BMVL01000013.1:
Lanthipeptides: IE257_RS28650_lanthipeptide
14
LGNKGAYCTLTVECMPSCN
32
LGN G CT+TVEC +C
15
LGNNGHLCTVTVECQKNCQ
33
31.7%
NZ_NTSR01000029.1:
Lanthipeptides: CN358_RS25180_lanthipeptide
7
WYNISCRLGNKGAYCTLTVECMPSCN
32
+ +S LGN G CT TVEC +CN
16
YIKLSIGLGNNGYICTYTVECQKNCN
41
31.6%
NZ_BMRY01000003.1:
Lanthipeptides: IE140_RS12370_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
Y S LGN G +CT T EC +C
14
YGASYVLGNNGNFCTATAECQNNC
37
31.6%
NZ_WHOM01000078.1:
Lanthipeptides: GCN81_RS29300_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
Y S LGN G +CT T EC +C
14
YGASYVLGNNGNFCTATAECQSNC
37
31.4%
NZ_CP092836.1:
Lanthipeptides: MLD62_RS30280_lanthipeptide
8
YNISCRL-------GNKGAYCTLTVECM
28
YN+S + GN G +CT + ECM
1
YNLSAAIADAAGLKGNYGKFCTYSAECM
28
31.2%
NC_016582.1:
Lanthipeptides: SBI_RS34375_lanthipeptide
15
GNKGAYCTLTVECMPSCN
32
G G +CTL+ EC P+CN
3
GGFGLFCTLSKECQPNCN
20
31.2%
NZ_BQME02000001.1:
Lanthipeptides: MFF31_RS04105_lanthipeptide
15
GNKGAYCTLTVEC
27
GN G YCTLT EC
9
GNDGKYCTLTWEC
21
31.2%
NZ_CP061033.1:
Lanthipeptides: IAU67_RS09320_lanthipeptide
14
LGNKGAYCTLTVECMPSCN
32
LGN+G +CT T+EC +C
4
LGNEGNFCTGTIECQKTCQ
22
31.2%
NZ_FMPI01000012.1:
Lanthipeptides: BJR39_RS08305_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+++S GN G +CT + ECM C
6
FSLSDYWGNNGNWCTASHECMSWC
29
31.2%
NZ_FNHR01000005.1:
Lanthipeptides: BLQ37_RS05590_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+++S +GN G +CT++ ECM C
6
FSLSDYMGNNGNWCTISHECMAWC
29
31.2%
NZ_MIFN01000022.1:
Lanthipeptides: BHL26_RS15350_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+++S GN G++C+L+ ECM C
6
FSLSDYWGNDGSWCSLSHECMSWC
29
31.2%
NZ_NUIO01000031.1:
Lanthipeptides: CN977_RS23160_lanthipeptide
8
YNISCRLGNKGAYCTLTVECMPSC
31
+++S GN G++CT T EC+ C
6
FSLSDYWGNDGSWCTATHECLSWC
29
31.0%
NZ_BMFU01000012.1:
Lanthipeptides: IEW26_RS25375_lanthipeptide
14
LGNKGAYCTLTVECMPSCN
32
+GN G CTLTVEC SCN
24
MGNPGHVCTLTVECQKSCN
42
30.6%
NC_017299.1:
Lanthipeptides: H04402_RS03105_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSCN
32
+S +GN G CT TVEC +C+
11
LSVYMGNDGKVCTWTVECQNNCS
33
30.6%
NZ_JAENHN010000066.1:
Lanthipeptides: JHL18_RS24425_lanthipeptide
14
LGNKGAYCTLTVECMPSCN
32
LGN+G C+LT EC CN
6
LGNQGKKCSLTRECQRLCN
24
30.6%
NZ_JAGKQT010000007.1:
Lanthipeptides: J2M30_RS09860_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSC
31
+S +GN G CT TVEC+ +C
14
VSHFVGNDGKVCTYTVECVNNC
35
29.7%
NC_015215.1:
Lanthipeptides: SGGBAA2069_RS00705_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSCN
32
+S LGN G CT T EC +C
15
LSIGLGNDGWVCTWTAECQATCR
37
29.7%
NZ_CP047645.1:
Lanthipeptides: GSN02_RS17445_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSC
31
+S GNKG CT T EC +C
16
VSEVFGNKGKVCTGTKECQGTC
37
29.4%
NZ_CP040417.1:
Lanthipeptides: FE328_RS05345_lanthipeptide
5
CAWYNISCRLGNKGAYCTLTVECMPSCN
32
C W+N+SC LGN G CT + EC CN
23
CPWWNLSCHLGNDGKICTYSHECTAGCN
50
29.4%
NZ_WITJ01000001.1:
Lanthipeptides: GHI93_RS00065_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSC
31
++ LGN G CT T EC +C
12
VTLALGNNGYVCTWTHECQANC
33
28.9%
NZ_JAQFWW010000002.1:
Lanthipeptides: PDT38_RS11330_lanthipeptide
11
SCRLGNKGAYCTLTVECMPSC
31
S +G+KG CT TVEC +C
16
SIMIGDKGQVCTGTVECQNNC
36
28.9%
NZ_LT575476.1:
Lanthipeptides: BN6628_RS02285_lanthipeptide
14
LGNKGAYCTLTVECMPSCN
32
LG+KG CT TVEC+ +C
19
LGDKGQVCTATVECINNCR
37
28.1%
NZ_BOSN01000007.1:
Lanthipeptides: KJS43_RS18005_lanthipeptide
15
GNKGAYCTLTVEC
27
GN G YCT+T EC
10
GNDGKYCTITWEC
22
28.1%
NZ_JAMDLZ010000027.1:
Lanthipeptides: M5W82_RS15515_lanthipeptide
15
GNKGAYCTLTVEC
27
GN G +CTLT EC
9
GNDGKWCTLTWEC
21
27.9%
NZ_QORY01000016.1:
Lanthipeptides: DT250_RS18255_lanthipeptide
14
LGNKGAYCTLTVECMPSCN
32
LGNKG CT T+EC CN
19
LGNKGRICTYTLECTAGCN
37
27.8%
NZ_CP086141.1:
Lanthipeptides: LL065_RS24800_lanthipeptide
14
LGNKGAYCTLTVECMPSC
31
LGN+G CT +VEC +C
19
LGNQGKICTWSVECQNNC
36
27.5%
NZ_FQZK01000006.1:
Lanthipeptides: BUE45_RS13115_lanthipeptide
14
LGNKGAYCTLTVECMPSC
31
+GN G CTL+VEC SC
23
IGNPGWACTLSVECQGSC
40
27.3%
NZ_AUCI01000015.1:
Lanthipeptides: G475_RS0114640_lanthipeptide
15
GNKGAYCTLTVEC
27
GN G YCT+T EC
11
GNDGDYCTITWEC
23
27.0%
NZ_VTZW01000015.1:
Lanthipeptides: FZ103_RS15850_lanthipeptide
14
LGNKGAYCTLTVECMPSC
31
+GN+G CT+TVEC C
20
VGNEGWACTVTVECQDGC
37
26.8%
NZ_FQZK01000006.1:
Lanthipeptides: BUE45_RS13060_lanthipeptide
10
ISCRL---GNKGAYCTLTVEC
27
I+C L N G +CT+TVEC
14
IACALLSRNNTGRFCTVTVEC
34
25.0%
NZ_CM001792.1:
Lanthipeptides: C794_RS17980_lanthipeptide
15
GNKGAYCTLTVECMPSCN
32
GN+G +CT+T EC +CN
21
GNQGWFCTITKECQVNCN
38
24.3%
NZ_CP115450.1:
Lanthipeptides: O1G21_RS35415_lanthipeptide
14
LGNKGAYCTLTVECMPSCN
32
+GN G CT+T EC +C
18
MGNNGYLCTVTAECQKNCQ
36
21.9%
NZ_CP011152.1:
Lanthipeptides: WR47_RS28820_lanthipeptide
10
ISCRLGNKGAYCTLTVECMPSCN
32
IS LGNKG CT+T EC CN
42
ISNTLGNKGHACTITKECQNMCN
64
MIBiG 3.1 matches for BH0454
87.5%
BGC0000517 (BAB04173.1):
Lanthipeptide: haloduracin β or haloduracin α
5
CAWYNISCRLGNKGAYCTLTVECMPSCN
32
CAWYNISCRLGNKGAYCTLTVECMPSCN
1
CAWYNISCRLGNKGAYCTLTVECMPSCN
28
43.8%
BGC0002110 (QKV49893.1):
Lanthipeptide: birimositide
8
YNISCRLGNKGAYCTLTVECMPSCN
32
+++S LGN G +CTLT EC P+CN
6
FSLSNALGNNGGWCTLTKECQPNCN
30
20.5%
BGC0001229 (SBI_06990):
Lanthipeptide: SBI-06990 A1 or SBI-06989 A2
21
CTLTVECMPSCN
32
CTL+ EC P+CN
28
CTLSKECQPNCN
39
with 1 more sequence matches
Legend:
Dha: Didehydroalanine
Dhb: Didehydrobutyrine